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1. Summary 
 
Pancreatitis is a severe inflammation of the pancreas and a major risk factor for developing 
pancreatic ductal adenocarcinoma, a human malignancy associated with a 5-year survival 
rate of less than 5%. A key step in the malignant transformation is the formation of acinar-to-
ductal metaplasia (ADM), where acinar cells de-differentiate into a progenitor state 
characterized by the appearance of tubular complexes. Importantly, a transient ADM 
formation and concomitant acinar cell proliferation has also been observed during 
pancreatitis both in humans and rodents, suggesting that the plasticity of acinar cells and 
their ability to de-differentiate into progenitor cells are crucial processes for pancreas 
regeneration. The mechanisms behind proliferation of acinar cells and metaplastic processes 
remain elusive because physiological factors that drive their regulatory network have not 
been fully identified. In this research project we wanted to investigate mitotic and anti-mitotic 
factors that contribute to acinar cell proliferation and ADM formation during pancreatitis. 
In the search for key molecular events that regulate ADM, we analysed the contribution of 
the cell cycle regulatory molecule p21waf1/cip1 in initiating ADM and acinar cell proliferation 
during pancreatitis. By using a genetically engineered mouse strain deficient in p21, we could 
show that loss of p21 increased the extent of ADM formation without altering the ability of 
acinar cells to replicate. These data revealed that p21 regulates acinar cell de-differentiation 
independently from cell cycle modulation. Importantly, loss of p21 was accompanied by 
increased expression of β-catenin and development of senescence and in many ways both 
of these factors can contribute to ADM formation. Thus, our results indicate that p21 acts as 
a molecular switch limiting senescence and ADM formation.  
In the second project we investigated the importance of extracellular factors in ADM 
formation.  TGF-β signalling plays an essential role in tissue repair and we analysed the 
contribution of TGF-β signalling in acinar cell proliferation and ADM formation. To address 
these questions we generated transgenic mice lacking TGF-β receptor II (TGF-β RII) in 
pancreatic epithelial cells. Our mouse model showed that TGF-β signalling is necessary to 
limit ADM formation, most likely via crosstalk with EGFR signalling. Moreover, the data also 
revealed a weak anti-mitotic activity of TGF-β in acinar cells that is elicited by controlling the 
expression of the cell cycle regulator p16. Collectively, TGF-β signalling restrains both ADM 
formation and acinar cell proliferation, indicating its dual role during pancreatitis. 
In the third project we investigated the mitogenic effects of serotonin, a well-known stimulator 
of cell proliferation, in ADM formation and acinar cell proliferation.  More specifically, by using 
a genetically engineered mouse strain deficient in peripheral serotonin, we showed that the 
absence of serotonin delayed ADM formation and elicited a minor reduction of acinar cell 
proliferation. We proposed a possible mechanism of serotonin mediated ADM formation by 
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showing that serotonin stimulated acinar cell secretion and progenitor gene expression both 
processes being a pre-requisite for ADM formation. Our findings indicate that serotonin 
promotes de-differentiation of acinar cells and ADM formation following pancreatitis. 
Significance of the project: 
The results of this research indicate the contribution of pro- and anti-proliferative molecules 
in ADM formation and acinar cell proliferation during pancreatitis. It has been previously 
demonstrated that p21, TGF-β and serotonin regulate cell proliferation in different tissues. 
However, our analysis showed unique roles of these three molecules in pancreatic pathology 
where they regulate more ADM formation than cell proliferation. The characterization of this 
regulatory mechanism in pancreatic injury advanced our understanding of the control of 
pancreatic regeneration. However, still a lot of work needs to be done to fully characterize 
the regulatory network of ADM and pancreatic regeneration in order to reveal novel 
therapeutic strategies to block ADM progression towards pancreatic cancer.     
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2. Zusammenfassung 
 
Pankreatitis ist eine entzündliche Erkrankung der Bauchspeicheldrüse. Sie erhöht die 
Wahrscheinlichkeit an Pankreaskrebs zu erkranken, bei dem die 5-Jahre Überlebensrate 
weniger als 5% ist. Ein kritischer Prozess für Entstehung von Pankreaskrebs  ist die Bildung 
von Azinus-zu-Dukt Metaplasien (ADM). ADM beinhaltet charakteristischerweise, eine 
Dedifferenzierung zu Vorläuferzellen und schliesslich die Ausbildung von tubulären 
Komplexen. Sowohl in Menschen wie auch in Nagetieren wurden während der Pankreatitis 
vorübergehende ADM beobachtet, einhergehend mit einer erhöhten Proliferation von 
Azinuszellen, sowie einer Proliferation in den ADM selbst. Dieser Prozess deutet auf eine 
Plastizität der Azinuszellen hin, und spielt damit eine wichtige Rolle bei der Regeneration des 
Pankreas. Die genauen Mechanismen, die  für die azinäre Proliferation und die 
metaplastischen Veränderungen verantwortlich sind, sind noch unklar, da die Faktoren noch 
nicht komplett identifiziert wurden. In dieser Studie wollten wir pro- und anti-mitotischen 
Faktoren charakterisieren, die Proliferation und ADM kontrollieren. 
Daher wurde auch die Funktion des Zellzyklus Inhibitors p21waf1/cip1 während der Pankreatitis 
untersucht. Zur Untersuchung nutzten wir genetisch modifizierte Mäuse, denen das Gen für 
p21waf1/cip1 fehlt. Diese Mäuse zeigten eine erhöhte Bildung von ADM Beeinträchtigung der 
Zellproliferation. Diese Ergebnisse lassen darauf schliessen, dass p21 die azinäre 
Dedifferenzierung reguliert, ohne den Zellzyklus zu modulieren. Ausserdem geht der Verlust 
von p21waf1/cip1 mit einer Erhöhung der Expression von β-Catenin einher, sowie einer azinären 
Zell-Seneszenz. Beide Faktoren scheinen die ADM Bildung zu beeinflussen. Diese Resultate 
implizieren, dass p21waf1/cip1 ein molekularer Schalter bei der Seneszenz und ADM Bildung 
ist. 
In einer zweiten Studie untersuchten wir extrazelluläre Faktoren, die zur Bildung von ADM 
beitragen. TGF-β spielt eine wichtige Rolle in der Wundheilung. Deshalb untersuchten wir die 
Signalkaskade in azinären Zellen und ADM, die durch TGF-β ausgelöst wird. Für diese 
Untersuchungen wurden transgene Mäuse hergestellt, deren TGF-β Rezeptor (TGF-β RII) 
selektiv im Pankreasepithelium fehlt. Dieses Mausmodell hat gezeigt, dass TGF-β die 
Bildung von ADM inhibiert, wahrscheinlich über die Aktivierung des EGF-Rezeptors. 
Ausserdem wurde eine anti-mitotische Aktivität von TGF-β in Azinuszellen beobachtet. Dabei 
wird angenommen das p16, ein Zellzyklusinhibitor, aktiviert wird. Zusammenfassend konnten 
wir eine Doppelrolle von TGF-β in der Regulation von ADM, sowie eine Inhibition der 
azinären Proliferation im Pankreas feststellen. 
Im dritten Projekt untersuchten wir die Funktion von Serotonin in der ADM Bildung und 
azinären Proliferation. Serotonin ist ein bekannter mitotischer Faktor. Zur Untersuchung 
verwendeten wir eine transgene Maus, die kein peripheres Serotonin produzieren kann. In 
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diesem Modell war die ADM Bildung verzögert und die azinäre Proliferation leicht reduziert. 
Unsere Daten deuten darauf hin, dass Serotonin an der Sekretion sowie der Rekrutierung 
von Vorläuferzellen beteiligt ist. Beide Prozesse sind Voraussetzung für die Bildung von 
ADM. Wir schliessen daraus, dass Serotonin die Dedifferenzierung von azinären Zellen und 
die Bildung von ADM während der Pankreatitis fördert. 
Signifikanz des Projektes 
Die Resultate unserer Untersuchungen unterstreichen die Bedeutung von pro- und anti-
mitotischen Faktoren bei der Bildung von ADM sowie der azinären Proliferation bei der 
Pankreatitis. Es war bekannt das p21, TGF-β und Serotonin die Proliferation in 
verschiedenen Geweben kontrollieren. Unsere Analysen der pathologische Veränderungen 
im Pankreas konnten nun zeigen, dass die Kontrolle der ADM Bildung durch diese Faktoren 
eine neuartige Funktion darstellt. Die Aufklärung dieser Mechanismen vertieft unser 
Verständnis der pathophysiologischen Veränderungen nach einem Gewebeschaden und 
offenbart neue mechanistische Aspekte der Pankreasregeneration. Nichtsdestotrotz, sind 
weitere Untersuchungen nötig, um die Regulation der Bildung von ADM während der 
pankreatischen Regeneration zu verstehen und allfällige therapeutische Ansätze 
aufzuzeigen. 
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3. Introduction 
3.1 Pancreas 
 
Anatomy 
The pancreas is a glandular organ in the digestive and endocrine systems of vertebrates. It is 
the organ that probably most people have never thought about, but it can be felt after 
overeating when a feeling of vague and localised visceral pain arises.  The pancreas lies in 
the abdomen behind the stomach and is surrounded by the duodenum. Anatomically, it is 
divided into head, where the greatest mass of the organ is concentrated, body and tail. The 
head of the pancreas is connected to the duodenum while the body and the tail angle 
distinctly as they approach the spleen. The pancreas secretes pancreatic juice, a thick, 
colourless, alkaline fluid containing all pancreatic enzymes. The main channel for pancreatic 
juice drainage is the main pancreatic duct. It begins in the tail, runs through the body and 
ends in the head, along the way connecting with many secondary ducts. Also the common 
bile duct passes through the head of the pancreas and joins the main pancreatic duct at 
entering the duodenum (see Figure 1). 
The pancreas as a double gland 
The pancreas is a secretory organ which contains an endocrine and exocrine tissue. The 
endocrine part constitutes ~5% of the organ and the exocrine part nearly 95% of the 
pancreatic mass. The endocrine part of the organ is embedded in the exocrine tissue and 
contains β, α, δ, PP and ε cells that produce and release hormones like insulin, glucagon and 
somatostatin into the blood stream and control the metabolism of carbohydrates. The 
exocrine part consists of acinar and ductal cells. Acinar cells synthesize digestive enzymes 
and store them in zymogen granules. Ductal cells not only form pancreatic ducts but also 
secrete bicarbonates, ions and fluids that are necessary for draining zymogens into the 
duodenum where they are activated and participate in the carbohydrate, protein and lipid 
break down. Importantly, bicarbonates are required for stomach acid neutralisation at the 
entrance to the intestine in order to protect the intestine from acidity. Acinar cell digestive 
enzymes and ductal cell bicarbonates, ions and fluids form the pancreatic juice, the 
production of which can reach 1.5L per day.  
The pancreatic juice is drained through a complex network of ducts. Pancreatic ducts can be 
subdivided into three major groups according to their location. The first group, referred to as 
the intralobular ducts, occurs within the lobules and drains pancreatic juice from acini. The 
second group, consisting of interlobular ducts, occur in the interlobular connective tissue 
together with the major branches of vessels and nerves. The interlobular ducts then drain 
into the third duct group, the main pancreatic duct, which transverses the pancreas to the 
duodenum.  
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Secreted pancreatic proteins tend to form aggregates and a control of the pancreatic juice 
viscosity by bicarbonate, ion and fluid secretion is of a paramount importance to maintain the 
protein flow along the ducts.  
Vasculature 
The pancreas is permeated by blood vessels supplying the gland and this dense vasculature 
can become an utmost problem causing massive organ bleeding in case of pancreatic 
injuries or diseases. The pancreas receives the arterial blood supply from two arteries: the 
celiac and the superior mesenteric. Around 20% of the intrapancreatic blood flow is directed 
towards the islets where released hormones drain straight into the blood stream. 
Innervation 
The pancreas is waved by a dense network of neurons. Depending on the severity of 
pancreatic diseases, 80-95% of patients experience pain, which is the most common reason 
for searching medical help. [2] The pancreas is innervated by parasympathetic and 
sympathetic nervous systems and both types of nerve fibres mediate pain in the organ. The 
parasympathetic innervation originating from the vagus nerve also stimulates enzyme 
secretion.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Biology of exocrine cells 
The main enzyme-secreting units in the exocrine pancreas are acini, a round structure 
composed of pyramidal-shaped acinar cells bordering a common luminal space, which is 
connected with a ductal system. The acinar cell of the pancreas is polarized: the basal pole 
of the cell is mainly occupied by the endoplasmic reticulum and the apical pole by the Golgi 
complex and the zymogen granules. Zymogens are inactive enzymes synthesized and folded 
Figure 1: Adult pancreas anatomy and structure.  (Picture is taken from [1]) 
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in the endoplasmic reticulum, later sorted, packed and prepared for secretion in the Golgi 
complex. Interestingly, an acinar cell produces and secretes more proteins than any other 
adult cell. These proteins fall into three major categories of digestive enzymes: α-amylase, 
lipase and proteases, which are responsible for the hydrolysis of carbohydrates, fats and 
proteins, respectively. Secretion of digestive enzymes is stimulated by various hormones and 
by the parasympathic innervation of the pancreas. Secretin, cholecystokinin (CCK), gastrin 
releasing peptide (GRP), substance P, vasoactive intestinal peptide (VIP) and acetylcholine 
are mediators of enzyme secretion. After binding to their corresponding acinar receptors of 
the G-protein coupled family, these hormones trigger the process of receptor-mediated 
secretion.    
Acinar and ductal cell development 
The pancreas arises from the ventral and dorsal foregut epithelium by branching and forming 
multi-layered, stratified epithelium. This early pancreatic epithelium contains multipotent 
pancreatic progenitor cells with the potential to give rise to all pancreatic cell types (see 
Figure 2). The ‘tips’ of the branching epithelium contain progenitor cells, while the ‘trunk’ 
region give rise to islet and ductal cells. At day e13.5 ‘tip’ cells lose their multipotency and 
become acinar progenitor cells. After this period pancreatic cells undergo further growth and 
development. Developmental programs that are active in progenitor cells during embryonic 
development get activated once more during pancreatic injury, thus understanding the 
physiological molecular processes occurring during the development of the pancreas will 
help us understand better the pathological ones in the adult organ. [3] 
Acinar cell embryonic development is regulated by multiple mechanisms: on one hand by 
transcription factors that drive pancreas formation and on the other hand, by extrinsic signals 
and cell-cell interactions. Acinar cells derive from multipotent progenitors that co-express the 
homeobox protein PDX1, the Sry-box protein SOX9 and Ptf1a, a basic helix-loop-helix 
(bHLH) pancreas specific transcription factor active during embryogenesis which is later 
maintained only in adult acinar cells. In the absence of Ptf1a, acinar cells fail to develop and 
one reasons is that Ptf1a regulates the expression of acinar specific genes, including 
digestive enzymes like amylase and lipase. Acinar cell development is guided also by many 
other embryonic signals. For example, secreted pancreatic mesenchymal factors FGF10 and 
follistatin promote acinar cell specification. Notch signalling can repress acinar cell fate, 
while, Wnt signalling promotes progenitor and acinar cell proliferation.[4] 
Besides Ptf1a, mature acinar cells express many other acinar specific transcription factors, 
including Mist1, which is required for exocrine granule maturation, Gata6, which is required 
for mature acinar cell homeostasis, and Nr5a2, that is crucial for the maintenance of acinar 
identity. The absence of the last two transcription factors results in the loss of acinar cell 
phenotype.[5] 
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 Progenitor markers that drive ductal cell 
development have not been identified yet. 
Studies showed that a number of 
transcription factors like Sox9, Hnf1β, 
Hnf6 are involved in regulating specific 
aspects of ductal cell development during 
pancreas formation, however, none of 
them is specific for ductal cells only. 
Moreover, postnatal ductal cells express 
markers such as cytokeratin 19, cystic 
fibrosis transmembrane receptor, 
carbonic anhydrase II together with 
embryonic transcription factors. However, 
their expression is not uniform throughout 
different types of ducts, suggesting 
differences in ductal cells themselves. [6] 
More studies are necessary to elucidate the molecular mechanism of ductal cell formation 
and maturation. 
 
3.2 Pancreatitis 
 
While diabetes is the most prevalent disease of the pancreas, pancreatic cancer, which 
arises in the exocrine tissue, is far more aggressive and lethal compared to diabetes. 
Moreover, pancreatitis, which is a disease of the exocrine tissue associated with high 
morbidity and mortality, is considered a risk factor to develop pancreatic cancer. Taking into 
account these aspects, it is fair to highlight the importance of studies investigating the 
mechanism of pancreatitis. 
Pathology of pancreatitis 
Pancreatitis is an inflammatory disease of the pancreas that manifests itself in both acute 
and chronic forms. Acute pancreatitis presents clinically with abdominal pain and nausea and 
is diagnosed by measuring elevated lipase and amylase levels in the circulation. There are 
two forms of acute pancreatitis: a mild one, which resolves within days or weeks, and a 
severe one, which can be lethal due to multiorgan failure. Acute pancreatitis can be caused 
by a duct obstruction with gallstones, alcohol or tobacco abuse, infection or trauma. Chronic 
pancreatitis is most commonly associated with alcoholism and presents itself with a 
persistent abdominal pain. Acute and chronic pancreatitis can be linked, as recurrent 
Figure 2: Acinar and duct dells development during 
pancreas embryogenesis. (Picture is taken from [1]) 
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inflammatory events progress to a chronic disease. The low level of circulating digestive 
enzymes in chronic pancreatitis is thought to be an indicator of acinar cell atrophy. [7] 
The incidence of pancreatitis ranges from 13 to 45 for the acute form and from 5 to 12 for the 
chronic form per 100 000 people. [8, 9] Pancreatitis prognosis is variable, according to the 
severity of the disease and despite its relative rarity, pancreatitis continues to cause 
significant morbidity and mortality throughout the world.  
Mechanism of pancreatitis 
Following pancreatic injury early changes occur in acinar cells, including a block in secretion, 
co-localization of zymogens and lysosomal enzymes, intracellular activation of trypsinogen 
and other zymogens that result in acinar cell injury. As a result of injury, acinar cells release 
chemokines and cytokines, which initiate the recruitment of inflammatory cells into the tissue. 
In very severe cases, uncontrollable autodigestion results in the extensive tissue necrosis.  
Multiple animal models of pancreatic injury exist, but the model of choice for studying the 
mechanisms of pancreatitis has become cerulein-induced pancreatitis. Cerulein is an analog 
of cholecystokinin (CCK), which is a major gastrointestinal hormone with a central role in 
pancreatic secretion. Physiological doses of CCK mediate pancreatic secretion and growth 
and do not cause pancreatitis. In contrast, supramaximal doses (i.e. concentrations 
exceeding the dose that induces a maximal amylase secretion) of CCK or cerulein inhibit 
pancreatic enzyme secretion and result in zymogen activation and acinar cell injury. A block 
in secretion alters pancreatic digestive enzyme and lysosomal hydrolase segregation and 
causes their co-localisation. This co-localisation results in trypsinogen activation by 
lysosomal cathepsin B, leading to autodigestion of the acinar cell. The importance of 
catepsin B during pancreatitis was shown by cathepsin B-deficient mice where trypsin activity 
was 80% lower than in wild-type mice. However, the pancreatic injury was decreased only by 
50% in cathepsin B-deficient mice, suggesting that cathepsin B is not the only hydrolase 
involved in zymogen activation.[10] 
Inflammation 
Cerulein stimulated secretion leads to overproduction of digestive enzymes and induction of 
endoplasmic reticulum (ER) stress. ER stress leads to immune cell attraction, most likely via 
NFκB-dependent cytokine synthesis. [7] NFκB is a regulator of cytokine induction and, in 
turn, a modulator of inflammation. During pancreatitis various cytokines and chemokines are 
synthesized and released, for example TNF-α, IL-6, IL-1β, MCP-1. Studies have 
demonstrated that pancreatic acini release significant amounts of TNF-α as early as 30min 
after cerulein stimulation and this leads to neutrophils attraction to the site of injury. [11] The 
significance of neutrophils in the pathogenesis of pancreatitis has been illustrated by reduced 
severity of pancreatitis following their depletion. Neutrophil penetration into the tissue is 
followed by invasion of macrophages, then T and B cells and in the last stage dendritic cells 
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[12]. The recruitment and activation of various inflammatory cells leads to further 
exacerbation of acinar cell injury caused by elevated synthesis of various pro-inflammatory 
mediators, such as IL-1, IL-2, TGF-β and ICAM-1. All these pro-inflammatory molecules also 
induce a fibrotic response by activating pancreatic stellate cells that are discussed in more 
detail in the next section.  
Pancreatic fibrosis 
As mentioned above, acute pancreatitis is a transient insult. However, when the injury is 
persistent or recurrent, the acute form of pancreatitis transforms to chronic. While acute 
pancreatitis is histologically described by oedema, acinar vacuolisation and fat or acinar cell 
necrosis, chronic pancreatitis is characterised not only by the mentioned features but also by 
persistent acinar cell atrophy, inflammation and fibrosis. Fibrosis is a typical feature of 
chronic pancreatitis (see Figure 3) defined by the accumulation of excessive amount of 
extracellular matrix (ECM) proteins. It develops primarily in the perilobular space where 
necrosis was located. Pancreatic stellate cells (PSCs) play an important role in fibrosis and, 
upon activation by pro-inflammatory mediators, produce collagen and other ECM proteins. In 
resting state, PSCs are located in the periacinar and interlobular area, contain lipid droplets 
and store vitamin A. [13] PSCs also express vimentin, desmin and nerve growth factor, but 
hardly any ECM proteins. TGF-β1, PDGF, FGF-2, TNF, IL-1 and IL-6 activate PSCs, which 
then acquire a myofibroblast-like phenotype, with the disappearance of their lipid droplets 
and the expression of α-smooth muscle actin. In parallel, stimulated PSCs proliferate, 
migrate and deposit ECM proteins and matrix metallo-proteinases. [14] PSCs are also 
involved in perpetuating chronic inflammation. Indeed, activated PSCs synthesize and 
secrete growth factors and cytokines that attract inflammatory cells and thus linking the 
inflammatory response with fibrosis. 
Treatment of pancreatitis 
As of today, no specific causal treatments for pancreatitis exist. The goals of treatment for 
pancreatitis are to relieve pain, calm the disease process to prevent recurrent attacks, 
correct metabolic consequences such as diabetes and malnutrition, and manage 
complications when they arise. The main therapeutic approaches to pancreatitis are 
restricted to regular analgesics, maintaining an adequate intravascular volume by 
rehydration, diet adjustments, surgery and sometimes antibiotic intake in order to manage 
infections. [9] The lack of an effective cure is partially linked to a limited understanding of the 
disease progression at the molecular level. In addition, the treatment of pancreatitis would 
also benefit from the availability of better diagnostic tools, because patients present 
themselves at a late stage of disease when the injury began to progress to a systemic phase.    
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 3.3 Acinar-to-ductal metaplasia (ADM) 
 
Introduction to pancreatic metaplasia 
Pancreatitis is often associated with metaplasia, which is detected in the diseased pancreas 
in both humans and animal models. Metaplasia is generally defined as a transformation of 
one tissue type into another [15]. Cells can be transformed into other cell types by either 
dedifferentiation or transdifferentiation. Dedifferentiation is a reversion of terminally 
differentiated cell to a less-differentiated stage within its own linage. Transdifferentiation 
indicates that a cell regresses to a point where it can switch lineages, allowing it to 
differentiate into another cell type. [16] Injury induced to the pancreas leads to the formation 
of acinar-to-ductal metaplasia (ADM), which presents itself as ductal-like lesions in 
pancreatic tissue (see Figure 3). ADM is thought to arise from acinar cells that lose their 
phenotype and form ductal structures. Cells within ductal structures have not only 
morphological similarities with pancreatic ducts but these cells also express ductal markers 
and, more importantly, re-express pancreatic progenitor markers, which are active during 
pancreas development.   
Morphologically, ADM is classified in [17]: 
• Type 1 tubular complexes (TC1), which have a wide lumen lined by very few flat cells 
• Type 2 tubular complexes (TC2), which are lined by many cells arranged in groups 
with branching.  
Acinar cell changes during ADM formation 
Pancreatic injuries and manipulations can induce a loss of the hallmark characteristics that 
identify a terminally differentiated acinar cell. During this process, acinar cells lose their 
specific proteins, like amylase, lipase and trypsin, and later shut down their expression 
totally. Also, a morphological remodelling of acinar cells takes place, which includes 
cytoplasm contraction and cytoskeleton rearrangement. Finally, a switch in gene expression 
Figure 3: The normal and injured pancreas. (a) A section of normal human pancreatic 
tissue with the outlined cluster of acinar cells (AC). (b) A section of human chronic 
pancreatitis specimen with indicated areas of fibrosis (FI) and acinar-to-ductal 
metaplasia (ADM). (Picture is taken from [6]) 
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is induced where the developmental or repair program is activated with the expression of 
genes that are active during pancreatic embryogenesis and in uninjured pancreas are 
restricted to duct cells, for instance Hes1, Hnf6 and Sox9. Despite the fact that acinar cells 
dedifferentiate to structures similar to ducts, which express many ductal and progenitor 
markers, these structures are not considered as real ductal or progenitor cells because they 
lack the expression of other markers, including Hnf1β and Nkx6.1 [18]. Recent studies 
showed that the extent and degree of dedifferentiation depends upon the duration of injury, 
suggesting that this is a protective response reducing the harmful effects of digestive 
enzymes and simultaneously generating a cell with progenitor-like qualities. Notably, the 
dedifferentiation process depends on interactions between acinar cells and immune cells, 
which almost immediately from the time of injury participate in the process acting as critical 
regulators of ADM [7]. 
Regulators of ADM 
Among the first events occurring during pancreatic injury is an influx of inflammatory 
leukocytes, which amplify the severity of the injury. Macrophages are one set of immune 
cells that are associated to acinar cells undergoing metaplasia and their depletion before 
pancreatitis significantly reduces ADM formation [19]. In contrast to macrophages, T and B 
cells did not show any effect regarding ADM formation, however, the resolution of ADM is 
impaired when the immune system lacks both T and B cells [20]. Moreover, pancreatic injury 
is associated with abundant production of inflammatory cytokines, which originate and act on 
both acini and leukocytes. Cytokine implication in ADM formation has been shown in 
transgenic mice overexpressing IL-1β, LTαβ or TGFα, where each of these molecules was 
sufficient to induce ADM [21-23]. TGFα  is a ligand of the epidermal growth factor receptor 
(EGFR), the activation of which causes not only ADM formation both in vitro and in vivo, but 
also accelerates pancreatic tumorigenesis [24]. However, how EGFR exactly promotes ADM 
remains incompletely understood and requires further investigations. 
Embryonic signalling pathways, active during pancreas organogenesis, are normally 
excluded from adult acinar cells but become reactivated upon injury. Analysis of animal 
models revealed that Notch, Hedgehog (HH), Hippo and Wnt/β-catenin signalling pathways 
are re-expressed in pancreas following injury. Notch and HH signalling pathways, which 
exert opposite effects during pancreatic development, have a similar role after pancreatic 
injury and promote ADM resolution and acinar cell re-differentiation [25, 26]. The Hippo 
pathway is necessary for maintaining acinar cell identity and, in the absence of Mst1 and 
Mst2 Hippo kinases, acinar cells dedifferentiate forming ADM. The Wnt/β-catenin pathway 
promotes acinar cell proliferation during pancreas formation and is necessary for ADM 
resolution [27]. All in all, the immunity and the developmental signalling pathways appear to 
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play opposite roles: the first is important in promoting ADM and the second one in resolving 
it.  
As already mentioned above, there are many pancreatic transcription factors (TF), which are 
differentially activated and regulated in three states of the organ: pancreas development, 
adult pancreas and injured pancreas. Many of them have been studied to investigate how 
their absence or presence in combination with or without injury, influences ADM formation or 
resolution. For example, the potency of ductal TFs HNF6 and Sox9 to induce ADM was 
analysed by adenoviral overexpression [28]. While HNF6 overexpression was sufficient to 
induce ADM, Sox9 overexpression could only destabilise acinar cells by forcing them to 
express ductal cell marker cytokeratin 19. However, when conditional Sox9 deletion was 
coupled with cerulein pancreatitis it did not reveal any significant difference in ADM formation 
between knockout and control animals [29]. These results indicate different capacity of ductal 
TF to dedifferentiate acinar cells: HNF6 is a more potent inducer of metaplasia compared to 
Sox9, which alone cannot drive ADM formation.  
Another set of TFs regulating ADM formation includes Mist1, GATA6 and Nr5a2, which are 
required for normal acinar cell differentiation. Inactivation of Mist1 by overexpression of 
dominant-negative form or by genetic deletion led to induction of ductal cell marker 
expression [30]. When the genetic deletion was coupled with cerulein pancreatitis, this 
accelerated metaplasia formation. Particularly critical TFs for maintaining acinar cell identity 
are GATA6 and Nr5a2, the disruption of which abolished acinar cell terminal differentiation 
[31, 32]. All these TFs bind to and activate most of acinar specific genes and together 
constitute a master regulatory network for acinar differentiation. A disruption of one of these 
TFs is sufficient to down-regulate acinar specific genes and activate the ductal phenotype. 
Importance of ADM 
The studies discussed above indicate the remarkable ability of acinar cells for plasticity and 
cell fate changes, meaning that these cells can transiently or stably adopt duct-like 
characteristics. This capability depends on molecular and environmental factors that 
reactivate developmental programs in response to injury or immune reaction.  
Why are acinar cell plasticity and ADM important? The main reasons are pancreatitis and 
pancreatic cancer. Pancreatitis is associated with ADM and its resolution depends on re-
differentiation and re-establishment of normal acinar cell function. Studies investigating 
pancreatic cancer indicate that precursor lesions of this disease arise from ADM [33]. 
Moreover, many of the same genes and pathways that promote metaplasia also promote the 
development of pancreatic cancer. Many studies describing the plasticity of acinar cells 
during pancreatic diseases highlight the fact that by understanding the mechanisms of 
metaplasia, new therapeutic approaches could be identified for pancreatitis and pancreatic 
cancer treatment. 
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3.4 Aims of the project 
 
The exact molecular mechanisms regulating the development of ADM are not completely 
elucidated. Pancreatic injuries induce ADM formation but, what is more important, also force 
acinar cells and notably ADM itself to proliferate. To investigate and better characterize ADM 
we analysed how pro- or anti-proliferative factors affect ADM. Specifically, to investigate 
ADM formation we addressed the following questions: 
1. What is the role of p21Waf1/Cip1 in ADM formation? p21Waf1/Cip1 is a powerful inhibitor of 
cell proliferation, as it controls cell cycle progression at G1-S and G2-M transitions. 
We hypothesised that in the absence of p21Waf1/Cip1 proliferation should increase not 
only in acinar cells but in ADM areas as well, possibly leading to ADM expansion. To 
answer this question we used WT and p21Waf1/Cip1 knockout mice, which were 
exposed to different regimens of cerulein treatment in order to induce pancreatitis. 
2. What is the role of TGF-β signalling in acinar cell proliferation and ADM formation 
during pancreatitis progression? One of many TGF-β signalling functions is induction 
of cell cycle arrest through cyclin-dependent kinase (Cdk) inhibitors. We hypothesised 
that inhibition of TGF-β signalling in pancreatic epithelial cells should increase acinar 
cell proliferation and possibly ADM formation. To analyse the role of TGF-β signalling 
in pancreatic epithelial cells we used a conditional, pancreas specific TGF-β receptor 
II (TGF-β RII) knockout mouse model. To induce pancreatitis we exposed control and 
TGF-β RII knockout mice to different regimens of cerulein and analysed pancreatic 
regeneration.    
3. What is the role of serotonin in ADM formation? Serotonin is a potent mitogen with a 
pro-proliferative effect in many adult tissues. We hypothesised that in the absence of 
serotonin proliferation of pancreatic acinar cells and concomitant ADM formation 
should be diminished. To investigate serotonin-dependent effects in pancreatic tissue 
we used transgenic mice deficient in peripheral serotonin (TPH1-/-). We compared 
these mice with WT animals in two regeneration models, which differed in the 
magnitude of regenerative stimuli: in one model, tissue injury was induced by cerulein 
treatment and in the other, tissue loss was obtained by partial pancreatectomy.  
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Abstract  
Trans-differentiation of pancreatic acinar cells into 
ductal-like lesions, a process defined as acinar-to-
ductal metaplasia (ADM) is observed in the course 
of organ regeneration following pancreatitis. In 
addition, ADM is found in association with pre-
malignant PanIN lesions and correlates with an 
increased risk of pancreatic adenocarcinoma 
(PDAC).  Human PDAC samples show down-
regulation of p21WAF1/Cip1, a key regulator of cell 
cycle and cell differentiation. Here we investigated 
whether p21 down-regulation is implicated in 
controlling the early events of acinar cell trans-
differentiation and ADM formation.  p21-mediated 
regulation of ADM formation and regression was 
analyzed in vivo during the course of cerulein-
induced pancreatitis using wild type (WT) and p21 
deficient (p21-/-) mice. Biochemical and 
immunohistochemical methods were used to 
evaluate disease progression over two weeks of the 
disease and during a recovery phase. We found 
that p21 was strongly up-regulated in WT acinar 
cells during pancreatitis, while it was absent in ADM 
areas, suggesting that p21 down-regulation is 
associated with ADM formation. In support of this 
hypothesis, p21-/- mice showed a significant 
increase in number and size of metaplasia. In 
addition, p21 over-expression in acinar cells 
reduced ADM formation in vitro, suggesting that the 
protein regulates the metaplastic transition in a cell-
autonomous manner. p21-/- mice displayed 
increased expression and re-localization of β-
catenin during both pancreatitis and subsequent 
recovery phase. Finally, loss of p21 was 
accompanied by increased DNA damage and 
development of senescence.  Our findings are 
consistent with a gate-keeper role of p21 in acinar 
cells to limit senescence activation and ADM 
formation during pancreatic regeneration.  
Keywords: senescence; p21; ADM; β-catenin; 
pancreatitis 
Introduction 
Pancreatitis is a severe inflammatory disease of the 
pancreas and its chronic and hereditary forms are a 
major risk factor for developing pancreatic ductal 
adenocarcinoma, a human malignancy associated 
with a 5-year survival rate of less than 5% [1]. A key 
step in the malignant transformation is the formation 
of acinar-to-ductal metaplasia (ADM), where acinar 
cells de-differentiate into a progenitor state 
characterized by the appearance of tubular 
complexes and reactivation of transcription factors 
and signaling pathways typical of pancreatic 
development [2-4]. Indeed, recent lineage tracing 
studies confirmed that reprogramming of 
differentiated acinar cells to ADM contributes to the 
formation of pre-malignant lesions [5]. Importantly, 
a transient ADM formation and concomitant acinar 
cell proliferation has also been observed during 
pancreatitis both in humans and rodents, 
suggesting that the plasticity of acinar cells and 
their ability to de-differentiate into facultative 
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progenitor cells are crucial processes for pancreatic 
regeneration. 
The molecular mechanisms regulating the 
development of metaplasia are not completely 
elucidated and their characterization would advance 
our knowledge not only of pancreatic regeneration 
but also of the progression to malignant lesions.  
Here, we investigated molecular factors which limit 
ADM formation. Specifically, we focused on 
p21WAF1/Cip1, a molecule with a complex network of 
intracellular functions. The molecule is known to 
inhibit cyclin/CDK activity, regulate apoptosis and 
senescence, and control transcription of specific 
genes [6-8].  Importantly, p21 is down-regulated in 
human pancreatic ductal adenocarcinoma [9, 10]. In 
addition, certain p21 polymorphisms are associated 
with increased risk of pancreatic adenocarcinoma 
[11], and improved survival was observed for 
patients whose adenocarcinoma was p21 positive 
[12], suggesting that p21 may indeed influence the 
susceptibility to and the outcome of pancreatic 
cancer.  
To address the role of p21 in ADM formation, we 
evaluated acinar trans-differentiation in vitro upon 
p21 over-expression in acinar cells and in vivo upon 
genetic ablation of p21. In the latter case, we used 
the controlled setting of cerulein-induced 
pancreatitis, which allows the analysis of 
metaplasia formation without the added complexity 
of cancer progression present in murine models of 
pancreatic cancer. 
Materials and methods 
Animal experiments 
All animal experiments were performed in 
accordance with Swiss Federal animal regulations 
and approved by the cantonal veterinary office of 
Zurich. Pancreatitis was induced in adult (8-10 
weeks of age) wild-type B6;129SF1/J and p21-/- 
(B6;129S2-Cdkn1a<tm1Tyj>/J, The Jackson 
Laboratories, USA) mice via six intra peritoneal 
(i.p.) injections of 50 µg/kg cerulein administered 
hourly over a two week period, as described in 
Supplementary Materials and Methods and [13]. 
Control animals received 0.9% NaCl injections.  
Histology, immunohistochemistry and 
immunoblotting 
Detailed protocols and primary antibodies used in 
this study are listed in Supplementary Materials and 
Methods. Quantification of labelled cells was 
performed in at least ten randomly selected high-
power fields (×100) per slide. Non-acinar tissue 
areas (islets, vessels, fibrotic tissue) were excluded 
from analysis. 
Transcript analysis 
Total RNA was extracted from pancreata as 
previously described [14] and reverse transcribed 
with qScript™ cDNA SuperMix (Quanta 
Biosciences). Transcript levels were normalized 
using 18S rRNA as a reference and expressed as 
fold induction relative to the value of untreated 
control animals. Taqman probes (Applied 
Biosystems) used in this study are listed in 
Supplementary Materials and Methods. 
Adenoviral infections 
Cultures of primary acinar explants isolated 
according to [15] and rat pancreatic AR42J cells 
(ATCC, CRL-1492) were maintained as described 
in Supplementary Materials and Methods. 
Adenovirus expressing p21 (Adp21) (rat) or green 
fluorescent protein (AdGFP) were purchased from 
Vector Biolabs (Philadelphia, PA) and added to 
acinar explants before embedding in collagen at the 
multiplicity of infection (MOI) described in the figure 
legends.  
Confocal microscopy and image analysis 
Analysis of fluorescently labeled β-catenin 
subcellular distributions was performed on a Leica 
SP2 AOBS confocal laser-scanning microscope 
(Leica Microsystems, Wetzlar, Germany) using a 
glycerol immersion objective lens (Leica, HCX PL 
APO CS 63x 1.3 Corr). Single optical sections in 
the central z-plane of the sample were collected 
with a pinhole setting of Airy 2 using constant 
settings for laser output and photomultiplier 
sensitivity. Both were adjusted to collect all signals 
within the linear range. Quantification of signal 
output within each micrograph (histogram 
quantification) was performed using the Leica 
applications software suite. The absolute signal 
output and the mean intensity in four arbitrarily 
positioned squares (regions of interest, ROI) of 
~8’500 µm2 within each of the 9 recorded 
micrographs per condition were measured in three 
biological replicates. To quantify the distribution of 
markers within the tissue section, i.e. plasma 
membrane/nuclei-associated vs. cytoplasmic signal 
(profile quantification), six arbitrarily positioned 
profile scans of ~70 µm length in each of the nine 
separate micrographs per condition were made. For 
statistical analysis the mean signal amplitudes and 
the mean variances of six profiles were calculated 
for each micrograph.  
Results 
p21 is up-regulated in acinar cells but not ADM 
during pancreatitis 
To investigate the function of p21 in ADM formation, 
we first assessed its expression in human samples 
of pancreatic diseases. p21 was abundantly 
expressed in areas with still intact acinar cells 
during chronic pancreatitis (Fig.1A a). However, in 
human pancreatic ductal adenocarcinoma, p21 
expression was comparatively modest in peri-
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tumoral lesions (Fig.1A b, c) and in advanced 
tumors [9, 10], suggesting that down-regulation of 
p21 is either a consequence of acinar trans-
differentiation and malignant transformation or it a 
prerequisite for the cells to transform.   
To determine whether down-regulation of p21 is 
required for acinar trans-differentiation, we 
analysed the temporal and spatial regulation of p21 
in mice following cerulein-induced injury, as this 
murine model allows us to investigate the initiating 
events of ADM formation without the added 
complexity of tumor progression. While p21 was 
barely detectable in the uninjured pancreas, its 
acinar expression (Fig. 1B) and transcript levels 
(Fig. 1C) increased robustly during cerulein 
treatment. Non-acinar compartments, including 
islets and ducts and interstitial cells, remained 
negative for p21 throughout the treatment (Fig. 1B, 
central panel, S1A). A negative control for the 
staining with the secondary antibody alone is shown 
in Fig. S1A. Moreover, transcript levels of p21 
transcriptional activators, including p53, TGFβ1 and 
its receptor TGFβ-RII, increased following cerulein 
treatment (Fig. 1C). Mist1, which directly induces 
p21 expression in pancreatic acinar cells [16], also 
increased one week after cerulein treatment (Fig. 
1C), following an initial transient reduction (Fig. 
S1B). Amylase, a down-stream target of Mist1, 
exhibited similar expression dynamics (Fig. S1B). 
These observations suggest that p21 expression 
may be induced via multiple pathways during 
pancreatitis. In stark contrast with the high 
expression of p21 observed in acinar cells, only 
minor amounts of the protein were detected in ADM 
areas, characterized by loss of acinar organization 
and tubular complex formation (Fig. 1B, asterisks).   
ADM is enhanced in the absence of p21 
As we observed low expression of p21 in ADM, we 
hypothesize that its down-regulation is a pre-
requisite for metaplastic transition. To test this 
hypothesis, we used mice lacking p21 (p21-/-) and 
quantified ADM lesions during cerulein-induced 
pancreatitis. Lack of p21 is compatible with normal 
development and pancreatic functionality [17], and 
results only in a modestly increased rate of 
spontaneous tumor development at advanced age 
[18-20]. Untreated p21-/- mice showed pancreata 
with normal cytoarchitecture and differentiated 
acinar cells with amylase content comparable with 
WT mice (Fig. 4B, C), indicating that p21 is not 
required for mouse pancreatic development and 
physiology. Eight hours after pancreatitis induction, 
serum levels of amylase (Fig. S2A) and lipase (Fig. 
S2B) were higher in p21-/- than in WT mice. 
Previous work showed that deletion of the p21 
inducer Mist1 resulted in higher enzymemia and up-
regulation of CCK receptor A [21, 22].  However, 
CCK-RA expression levels did not increase in the 
absence of p21 (Fig. S2C). WT and p21-/- mice 
showed comparable tissue morphology, as seen by 
H&E staining (Fig. S2D). In addition, eight hours 
after the beginning of the treatment both strains had 
similar up-regulation of apoptosis, quantified by 
TUNEL assay and cleaved caspase 3 (Fig. S3A, B), 
and autophagy, quantified by LC3-II western 
blotting and p62 immunostaining [23] (Fig.S3C, D). 
Infiltration of inflammatory cells (Fig. S3E, F) and 
cytokine/chemokine expression (Fig. S10A) was 
also comparable in the two strains. However, after 4 
days and one week of cerulein treatment, p21-/- 
mice presented more frequent and extended ADM 
lesions than WT animals, which then resolved after 
two weeks of treatment (Fig. 2A, B). As expected, 
immunohistochemical analyses confirmed that p21 
was absent in p21-/- mice (Fig. S4A). The prominent 
metaplastic lesions in p21-/- mice showed typical 
ADM features, including down-regulation of 
amylase and its transcription factor p48, cytokeratin 
accumulation and phospho-Stat3 expression. In 
addition, they were surrounded by collagen-rich 
stroma and activated stellate cells expressing α-
smooth muscle actin (αSMA) (Fig. 2C, D, S4B), as 
previously shown [24]. They expressed Sox9 and 
CD44, a type I transmembrane cell surface protein 
target of the APC-β-catenin-TCF pathway [25], and 
used as a marker for putative pancreatic cancer 
stem cells [26, 27]. Overall transcript levels of 
progenitor markers (Fig. S4C), as well as Sox9 
expression in intact acinar cells (Fig. S4D), were 
also slightly enhanced in the absence of p21. To 
investigate whether p21 directly regulates ADM 
formation, we overexpressed p21 by adenovirus 
infection in WT primary acinar explants embedded 
in three-dimensional fibrillar collagen and induced 
trans-differentiation by stimulation with TGF-α [28]. 
P21 over-expression reduced ADM formation in 
vitro (Fig. 2E), indicating that increased levels of 
p21 in acinar cells are sufficient to limit acinar trans-
differentiation. 
Acinar cell proliferation does not increase in the 
absence of p21 
p21 is a powerful inhibitor of cell proliferation, as it 
controls cell cycle  entry  by binding to and inhibiting 
cyclin-dependent kinases operating in both G1/S 
and G2/M  transition check points [8, 29]. Thus we 
evaluated whether the increased ADM formation in 
the absence of p21 is the result of increased acinar 
cell replication. Expression of both early (D1, E1) 
and late (A1, B1) cyclins, were significantly higher 
in p21-/- mice compared to WT animals after 
cerulein treatment (Fig. 3A, B). Similarly, transcript 
levels of both Cdc25B (Fig. S5A), and Cdc25C (Fig. 
3C, left panel), phosphatases that regulate the 
activity of cyclin B-Cdc2 kinase complex and cell 
cycle progression at the G2/M boundary [30], were 
higher in p21-/- mice, while expression of Cdc25A, 
which regulates the G1/S transition, was 
comparable in the two strains (Fig. S5A). 
Furthermore, activated Cdc25C, measured by the 
level of its phosphorylated form [31], was higher in 
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the absence of p21 (Fig. 3C, right panel). We found 
that p21 was expressed in proliferating acinar cells 
positive for the cell cycle activation marker Ki67 
(Fig. S5B, C). However, lack of p21 did not increase 
acinar cell proliferation, as seen by enumeration of 
cells positive for Ki67 (Fig. 3D, S6A), G1/S phase 
marker PCNA (Fig. S6A) and mitosis marker 
phospho-histone H3 (pH3) (Fig. S6A, B). 
Importantly, we did not observe any difference in 
proliferation between intact acinar cells and ADM 
(Fig. 3E), indicating that the two different types of 
epithelial cells have comparable replication rates, 
which are not regulated by p21.  These data 
indicate that, in response to injury, key cell cycle 
activators are up-regulated in mice lacking p21, yet 
the rate of mitosis is similar in both genotypes. 
Thus, activation of compensatory mechanisms may 
limit acinar cell proliferation in p21-/- mice.  
Lack of p21 does not compromise acinar 
recovery following pancreatitis 
Next we analysed whether the ability of the 
pancreas to recover from tissue injury is altered in 
the absence of p21. After a week of recovery 
following one week cerulein treatment, pancreata 
from both WT and p21-/- mice showed a normal 
histological phenotype indistinguishable from 
untreated animals (Fig. 4A, S7A). Similarly, the 
transition from the temporarily de-differentiated 
acinar cells to the terminally differentiated 
phenotype was efficient in the absence of p21, as 
shown by the restored amylase content  quantified 
by immunostaining (Fig. 4B), immunoblotting (Fig. 
4C) and enzymatic assay in both tissue and serum 
(Fig. S7B, C). ADM lesions recovered as well, and 
expression of their markers was reduced, as shown 
by Sox9 and CD44 staining (Fig. 4D, E) and 
autophagy was not detected (Fig. S7D). 
Collectively, these data show that lack of p21 allows 
not only a prompt de-differentiation during injury but 
also does not compromise the ability of the tissue to 
overcome the cerulein-induced damage.  
Lack of p21 results in increased β-catenin 
expression and re-localization 
To further characterize the molecular mechanisms 
responsible for the p21-dependent regulation of 
ADM formation, we investigated β-catenin, a 
transcriptional activator of the canonical Wnt 
pathway implicated in the regulation of 
differentiation and regeneration of acinar cells [2, 
32, 33]. Of note, β-catenin activation is sufficient to 
induce ADM formation [34]. As previously reported, 
quantitative confocal microscopy showed that 
cerulein treatment of WT mice up-regulated β-
catenin expression, which further increased during 
the week of recovery (Fig. 5A, B). β-catenin was 
mostly cytosolic in untreated mice, while it re-
localized to the plasma membrane and nuclei of 
acinar cells after pancreatitis induction (Fig. 5C), 
suggesting activation of Wnt signal transduction. 
Furthermore, β-catenin was present both in intact 
acini and ADM, where it presumably regulates 
CD44 expression [25] (Fig. 5D), indicating that β-
catenin-dependent signalling is not limited to 
metaplastic areas but influences the whole tissue. 
We observed that p21-/- mice displayed stronger β-
catenin labeling than WT mice after one week 
cerulein treatment and its expression, quantified by 
signal intensity, remained stable during the 
following recovery week (Fig. 5A, B).  In addition, 
we quantified the localization of β-catenin in plasma 
membranes and nuclei versus cytosol in the two 
strains, by measuring the variance of signal 
amplitude, as exemplified in Fig. 5E, left panels. β-
catenin re-localization to either plasma membranes 
or nuclei significantly increased in p21-/- mice 
compared with WT animals after one week cerulein 
treatment and became more cytosolic during the 
recovery time (Fig. 5E, right panel), suggesting  
faster dynamics of intracellular re-localization of the 
protein in the absence of p21. To investigate 
whether p21 directly regulates the expression of β-
catenin, we overexpressed p21 by adenovirus 
infection in AR42J acinar cells. These cells express 
β-catenin, mainly localized to the plasma 
membrane and nuclei, while p21 was present at low 
levels (Fig. S8A).  p21 overexpression did not 
change the levels of β−catenin (Fig. S8B), or the 
viability of AR42J cells (Fig. S8C), suggesting that 
p21 does not directly regulate β−catenin expression 
in this cell type. In addition, β-catenin expression 
and Wnt signaling were previously found to be 
inhibited or activated by p53 [35-38]. qPCR 
analyses showed similar p53 expression in WT and 
p21-/- mice (Fig. S8D), suggesting that β-catenin up-
regulation is not driven by aberrant p53 regulation.  
Lack of p21 results in increased DNA damage 
and senescence in acinar cells 
Expression and activation of β-catenin signaling has 
recently being shown to increase following DNA 
damage [39]. In addition, oxidative stress and DNA 
damage are regarded as major pathogenic factors 
in human and cerulein-induced pancreatitis [40]. 
Thus, we investigated whether loss of p21 was 
associated with increased DNA damage that could 
contribute to the observed β-catenin up-regulation. 
Expression of γH2AX, an early hallmark of active 
DNA damage response [41], was detected in 
mouse and human samples of chronic pancreatitis 
(Fig. 6A), while absent in untreated mice. γH2AX 
foci were more numerous in acinar cells and ADM 
areas of p21-/- mice after one week of pancreatitis 
(Fig. 6A, S9A). As DNA damage is a common 
cause of senescence [42], we tested whether 
senescence was promoted in absence of p21. 
Activity of acidic senescence-associated β-
galactosidase (SA-β-gal), a canonical marker of 
senescence (recently reviewed in [42, 43]) was 
negligible in untreated p21-/- mice (Fig. 6B), 
indicating that lack of p21 does not activate a 
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senescence program. However, following cerulein 
treatment these mice showed higher enzyme 
activity compared with WT animals, indicating that 
lack of p21 increased injury-induced senescence. 
Furthermore, additional senescence biomarkers, 
including the cyclin-dependent kinase inhibitors 
p16, were up-regulated in intact acini of p21-/- mice 
one week after experimental pancreatitis (Fig. 6C, 
S9B). Expression of the cyclin-dependent kinase 
inhibitor p27 increased in the absence of p21 (Fig. 
S9C), while the levels of cyclin B/Cdk1 inhibitors 
Myt1 and Wee1 were comparable in the two strains 
(Fig. S9D), indicating that expression of these 
factors is not altered in the absence of p21. In 
parallel with the increased DNA damage, the 
number of apoptotic cells both in intact tissue and 
ADM areas was more pronounced in the absence 
of p21 at one week of cerulein treatment (Fig. 6D). 
Finally, as senescent cells develop a secretory 
phenotype (SASP), which includes pro-
inflammatory factors such as IL-1β and IL-6 [44], we 
tested whether the increased senescence observed 
in the absence of p21 was accompanied by 
increased tissue inflammation. As shown in Fig. 
S10A, p21-/- mice did not show increased levels of 
pro-inflammatory transcripts one day after cerulein 
injection. However, concomitantly with the 
development of senescence after one week of 
treatment, p21-/- mice had increased 
cytokine/chemokine expression and recruitment of 
inflammatory cells in the pancreas (Fig. S10A, B), 
without increased fibrotic processes and activation 
of stellate cells (Fig. S11A-C). Altogether, these 
results show increased senescence in the absence 
of p21, suggesting that up-regulation of this protein 
during pancreatitis protects acinar cells from 
excessive accumulation of DNA damage and 
subsequent entry into a senescent state or cell 
death. 
Discussion 
p21 was initially characterized as a cyclin-
dependent kinase (CDK) inhibitor, however, further 
studies revealed that this molecule participates in a 
broader range of biological functions, spanning from 
regulation of DNA synthesis to stress response and 
control of cell differentiation [8]. Here we show that 
p21 was up-regulated in acinar cells during the 
development of pancreatitis and that its lack 
resulted in higher incidence of DNA damage and 
cellular senescence. Senescence is often mediated 
via independent activation of either p53/p21 or 
p16/pRb, but these pathways can cooperate [45] or 
substitute each other [46]. Previous studies 
associated p21 and p16 expression with 
senescence in acinar cells [47]. However, our data 
showed that p21 protects acinar cells from 
senescence and its loss results in increased 
senescence and expression of p16, thus confirming 
previous findings of p16 as a key regulator of 
senescence in the pancreas [48]. Collectively, our 
data suggest that p21 up-regulation during 
pancreatitis induces a temporary quiescence that 
may allow DNA repair and protects acinar cells 
against entry into a senescence program. Of note, a 
similar role of p21 in establishing quiescence and 
limiting senescence has been shown in few cell 
types, including human fibroblasts [49], murine 
skeletal muscle cells and adipocytes [50]. 
Conversely, p16 was shown to protect from DNA 
damage during p21-induced senescence in cells of 
the hematopoietic system, the small intestine, and 
the testes [51]. These recent reports highlight the 
observation that the senescence program can be 
differently regulated in different organ systems.  
In this study we also demonstrated an inverse 
correlation between the amount of p21 and the level 
of metaplastic transition, as lack or up-regulation of 
p21 resulted in increased or decreased ADM 
formation, respectively. Thus p21 may act as a 
tumor-suppressor in the adult pancreas. However, 
ADMs were transient also in p21-/- mice and acinar 
cells were able to re-activate the differentiation 
program, indicating that the absence of p21 alone is 
not sufficient to maintain a de-differentiated 
phenotype. The increased incidence of ADM 
formation observed in the absence of p21 may 
result from different mechanisms. First, lack of p21 
may increase the susceptibility of acinar cells to 
damage.  p21-/- mice had increased enzymemia 
eight hours after pancreatitis induction. However, 
tissue histology, apoptosis, autophagy and 
inflammation were comparable in the two strains in 
the acute phase of the disease, suggesting that lack 
of p21 is not associated with elevated cellular 
damage. Second, absence of p21 could affect the 
functionality of non-acinar cells, including stromal 
cells, whose activity may be necessary for proper 
regeneration of the injured parenchyma. Indeed, 
pancreatic stellate cells showed increased p21 
expression in vitro during senescence, a process 
which increases the efficiency of immune-mediated 
cytolysis and terminates pancreatic fibrogenesis 
[52].  Although we cannot dismiss an interaction 
with stromal cells completely, we found that 
expression of p21 in acinar cells is sufficient to 
regulate metaplastic transition in a cell-autonomous 
manner. 
In addition, previous studies have associated 
increased ADM formation with a defect in acinar cell 
replication, as recently shown for the loss of the 
polycomb group proteins Bmi-1 and Enhancer of 
Zeste Homolog 2 (EZH2) or Notch1 inhibition [53-
55]. Our results did not reveal a reduced mitotic rate 
in absence of p21, however the observed up-
regulation of cyclins without increased expression 
of mitotic markers suggests that an aborted 
replication in acinar cells may contribute to the 
enhanced metaplasia. These observations also 
indicate that adult acinar cells have a tightly 
controlled replication and, as observed in several 
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transgenic cancer models, that these cells are 
resistant to transformation leading to a malignant 
phenotype [56]. Of note, pancreatic β cells showed 
similar resilience to exit G1/0 arrest even under 
replication stimuli and loss of p21 was not sufficient 
to overcome the inhibitory control of the cell cycle 
[17, 57]. This argues for the presence of redundant 
or compensatory mechanisms regulating cellular 
replication of pancreatic cells.  
Finally, increased ADM may result from increased 
senescence developed in the absence of p21. The 
concept of senescence-induced ADM in the context 
of pancreatitis has not been thoroughly investigated 
yet. One intriguing possibility is that senescent cells 
secrete pro-inflammatory cytokines and proteases 
that may promote a microenvironment suitable for 
the development of ADM. In this context, we 
recently demonstrated that focal inflammation in the 
pancreas, independent from cerulein-induced injury, 
is sufficient to promote the formation of individual 
metaplastic lesions [58]. In addition, it is worth 
noting that several factors known to modulate ADM 
formation are also involved in senescence 
regulation. Specifically, Bmi-1 and EZH2, polycomb 
group transcriptional repressors that limit ADM in 
the pancreas [53, 55], are also known to inhibit 
senescence in different cells types [59, 60]. In 
addition, β-catenin, whose activation is sufficient to 
induce ADM formation [34], has recently been 
shown to mediate senescence and senescence 
associated secretory phenotype (SASP) in 
mesenchymal stem cells and cancer cells [61-63]. 
In our work, we found that absence of p21 is 
associated with an increase in β-catenin levels in 
the injured pancreas. Thus it is possible that 
following p21 loss, elevated β-catenin contributes to 
the increased senescence observed in the 
pancreas, and promotes the establishment of ADM 
during the course of pancreatitis.  
In conclusion, we showed that, in the course of 
pancreatitis, p21 acts as a molecular switch to 
promote quiescence of acinar cells and to limit DNA 
damage, activation of senescence and ADM 
formation. These data provide a new perspective 
not only on the biological response to injury in the 
pancreas but also on the complex molecular events 
governing pancreatic regeneration and the 
development of metaplasia.  
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Figure S1. P21 staining and transcript analysis of 
Mist1 and amylase during cerulein treatment. 
Figure S2. Serum enzyme levels, CCK receptor 
expression, tissue histology of p21 in WT and p21-/- 
mice after 7 days of cerulein treatment. 
Figure S3. Apoptosis, autophagy, inflammation 
analyses during cerulein treatment. 
Figure S4. Progenitor-cell markers regulation in the 
absence of p21. 
Figure S5. qPCR of Cdc25B and Cdc25A and co-
localization analyses during cerulein treatment. 
Figure S6. Immunostaining and quantification of 
proliferation markers during cerulein treatment. 
Figure S7. Analyses of acinar cell functionality after 
the recovery phase. 
Figure S8. P21 overexpression in AR42J cells.  
Figure S9. Cell cycle regulator expression in the 
absence of p21. 
Figure S10. Quantification of inflammation in the 
absence of p21. 
Figure S11. Quantification of fibrosis in the absence 
of p21. 
Figure legends 
Figure 1. A. Immunostaining of p21 showed that 
the protein is expressed in human samples of 
chronic pancreatitis (a), while it is only minimally 
present (arrows) in peri-tumoral areas of human 
pancreatic ductal adenocarcinoma (b, c).  Inset in a, 
enlarged view of p21 staining in acinar nuclei. 
Hematoxylin-Eosin (H&E) staining is shown in a’, b’, 
c’. B. Pancreatitis was induced in wild type 
B6;129SF1/J  (WT) mice with six injections of 50 
µg/kg cerulein administered hourly.  Animals 
received injections on Monday, Wednesday and 
Friday and were harvested on Tuesday after one 
set of injections (day 1), on Thursday after two sets 
of injections (day 3) or on Monday after three (day 
7) or six (day 14) sets of injections, without cerulein 
24 
 
treatment on the same day. Images show up-
regulation of p21 in acinar cells at day 7 after the 
beginning of cerulein treatment. Note the absence 
of staining in islets (red borders, i), ductal 
compartments (arrow), and interstitial cells 
(arrowheads). ADM areas (black borders, asterisk) 
in 7 day treated mice showed minimal p21 staining. 
Arrows indicate tubular complexes. C. qPCR of 
p21, p53, TGFβ, TGFβ receptor II and Mist1 levels 
in the pancreas of WT mice following 7 and 14 days 
of cerulein-induced pancreatitis. Results are 
average ± SEM (n=5). Scale bars: 50 µM. 
Figure 2. ADM is enhanced in the absence of p21. 
A. Hematoxylin-Eosin (H&E)-stained sections of 
pancreata at the indicated time of cerulein 
treatment showed extended regions of ADM 
(asterisks) in p21-/- mice after 4 and 7 days of 
pancreatitis. B. Quantification of ADM number 
following cerulein-induced pancreatitis. Data are 
normalized by the pancreatic area. Numbers above 
the bars indicate the average size of ADMs 
expressed as percentage of the total area of the 
pancreas. Results are average ± SEM (n>5), 
*p<0.05. C. Immunohistochemical analyses of p21-/- 
mice after 7 days of pancreatitis revealed that ADM 
areas (asterisks) were negative for the acinar cell 
markers amylase and p48, were positive for the 
ductal marker pan-keratin and phospho-Stat3 (p-
Stat3), contained collagen deposits and expressed 
the stem marker CD44. D. Co-localization analyses 
showed that ADMs expressed the progenitor 
marker Sox9 and were surrounded by stromal 
reaction with activated stellate (αSMA) and 
inflammatory (pan-leucocytes) cells. E. Primary 
acinar cells from WT mice were infected with 
adenovirus encoding either p21 (Adp21) or GFP 
(AdGFP) as control and embedded in collagen. 
TGFα-induced trans-differentiation was quantified 
after 7 days in culture. Results are average ± SEM 
(n=4), *p<0.05. Scale bars: 50 µM. 
Figure 3. Acinar cell proliferation does not increase 
in the absence of p21. A. qPCR revealed up-
regulation of early and late cyclins in p21-/- mice 
after cerulein treatment. B. Cyclin B 
immunostaining showed up-regulation of the protein 
in p21-/- mice after 7 days of cerulein treatment. C. 
qPCR of Cdc25C (right panel) and immunostaining 
of phospho-Cdc25C (left panel) showed up-
regulation and activation of the protein in p21-/- mice 
after 7 days of cerulein treatment. D. Quantification 
of Ki67 positive pancreatic acinar (Ac) and 
interstitial (Int) cells showed comparable 
proliferation rates in WT and p21-/- mice. E. 
Quantification of Ki67 positive cells in intact acini 
and ADMs showed comparable proliferation rates in 
WT and p21-/- mice. Results are average ± SEM 
(n=5), *p<0.05. Scale bars: 50 µM. 
Figure 4. Lack of p21 does not compromise acinar 
cell recovery. A H&E staining of pancreata showed 
that ADMs in p21-/- mice resolved to WT levels 
following one week of recovery. Immunostaining of 
pancreatic tissue (B) and immunoblotting (C) of 
20 µg proteins showed up-regulation of amylase in 
p21-/- mice following one week of recovery. Nuclei 
are stained with DAPI (blue). Immunostaining with 
Sox9 (D) and CD44 (E) revealed an almost 
complete disappearance of progenitor markers 
following one week of recovery. Results are 
average ± SEM (n=5), *p<0.05. Scale bars: 50 µM. 
Figure 5. Lack of p21 is associated with increased 
β-catenin expression and re-localization in acinar 
cells. A. Confocal analysis of β-catenin expression 
following 7 days of cerulein treatment (7 d) and 
recovery (7 d+rec). B. Quantification of β-catenin 
expression by measuring signal intensity as 
described in the Material and Methods section. C. 
Co-localization of β-catenin and DAPI indicating 
nuclear re-localization of the protein after 7 days of 
cerulein treatment. D. Co-localization of β-catenin 
(red) and CD44 (green) indicating β-catenin 
expression in ADM (asterisk). E. Quantification of 
intracellular β-catenin re-localization by measuring 
signal amplitude as described in the Material and 
Methods section. Left panel, examples of 
quantification in control and 7 day treated 
pancreata. Right panel, quantification of β-catenin 
re-localization (signal amplitude) during cerulein 
treatment and recovery. Note the increased signal 
amplitude in the treated samples indicating plasma 
membrane/nuclear re-localization of β-catenin. 
Results are average ± SEM (n=3), *p<0.05. Scale 
bars: 50 µM. 
Figure 6. DNA damage and senescence increased 
in the absence of p21. A. γH2AX immunostaining 
(upper panel) and quantification of positive cells 
(bottom panel) revealed increased DNA damage 
response following pancreatitis in the absence of 
p21. Asterisk indicates ADM. Right upper panel 
shows γH2AX immunostaining in human samples of 
chronic pancreatitis B. SA-β-galactosidase staining 
(upper panel) and enzymatic quantification (bottom 
panel) showed increased enzyme activity in p21-/- 
treated animals. C. qPCR (upper panels) and 
immunostaining (lower panels) showed increased 
expression of CDK inhibitors of the INK family in 
p21-/- mice after cerulein treatment. D. TUNEL 
staining showed increased number of apoptotic 
cells in intact acini in p21-/- mice after 7 days of 
cerulein treatment (left panel). High level of 
apoptotic cells was also detected in ADM areas 
(asterisk, right panel). Results are average ± SEM 
(n=5), *p<0.05. Scale bars: 50 µM. 
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Supplementary Online Material  
Material and Methods 
Pancreatitis induction 
Animals received six hourly injections of 50 µg/kg 
cerulein on Monday, Wednesday and Friday and 
were harvested on Tuesday after one set of 
injections (day 1), on Thursday after two sets of 
injections (day 3) or on Monday after three (day 7) 
or six (day 14) sets of injections, without receiving 
cerulein treatment on the same day. 
Primary acinar and AR42J cell cultures 
Primary acinar cell cultures were prepared 
according to [1]. Trans-differentiation was induced 
by addition of 50 ng/ml recombinant hTGF-α (R&D 
Systems). Cultures were maintained in Waymouths 
MB 752/1 medium supplemented with 50 U/mL 
penicillin, and 50 µg/mL streptomycin, 0.1% fetal 
bovine serum (FBS), 0.1 mg/ml soybean trypsin 
inhibitor, and 1 µg/ml dexamethasone, with daily 
medium replacement. AR42J cells were maintained 
in Kaighn’s modified Ham’s F-12 medium with 20% 
FBS, 50 U/mL penicillin, and 50 µg/mL 
streptomycin. Cells were incubated at 37°C in a 5% 
CO2 atmosphere. Cell death was quantified by 
trypan blue exclusion. AR42J cells were infected 
for 24 hours at the multiplicity of infection (MOI) 
described in the figure legends.  
Human Samples 
Human pancreas biopsy and serum samples were 
obtained from the University Hospital in Zurich. All 
samples were biobank registered and kept 
anonymous. The research project was authorized 
by the Ethics Committee of the Canton of Zurich 
(reference number, StV 26-2005). The study 
followed the ethical guidelines of the Helsinki 
declaration. 
Histology and immunohistochemistry  
Pancreas specimens were embedded in paraffin for 
histological analyses as described.[2] For 
immunofluorescence analysis of cultured cell lines, 
AR42J cells were fixed in 3.6% formaldehyde and 
permeabilized with 0.2% Triton X-100 in PBS. 
Primary antibodies used in this study were: rabbit 
anti-phospho-histone 3 (Millipore, Massachusetts, 
USA), rabbit anti-PCNA (Abcam, Cambridge, UK), 
mouse anti-p21 (BD Pharmingen, NY, USA), rabbit 
anti-β-catenin (Cell Signaling, Danvers, USA), 
rabbit anti-cyclin B (Cell Signaling, Danvers, USA), 
rabbit anti-p27 (Santa Cruz, Santa Cruz, USA), 
rabbit anti-stat3 (Cell Signaling, Danvers, USA), 
rabbit anti- Cdc25c-phospho T48 (Abcam, 
Cambridge, UK), rabbit anti-sox9 (Millipore, 
Massachusetts, USA), mouse anti-αSMA (Dako, 
Glostrup, Denmark), rabbit anti-amylase (Sigma-
Aldrich, Buchs, Switzerland), rabbit anti-Ki67 
(Abcam, Cambridge, UK), rabbit anti-PanKer (Cell 
Signaling, Danvers, USA), rabbit anti-p48 (gift from 
Helena Edlund, UMU), rabbit anti-coronin 1 (gift 
from Jean Pieters), rabbit anti-pu.1 (Cell Signaling, 
Danvers, USA), rabbit anti-p62/SQSTM1 (MBL, 
Massachusetts, USA). Secondary antibodies used 
in this study were: AlexaFluor 594 goat anti-rabbit 
IgG, AlexaFluor 488 goat anti-rat IgG (Life 
Technologies, Carlsbad, California, USA). Nuclei 
were visualized with 4′,6-diamidino-2-phenylindole 
(DAPI).  Detection of DNA fragmentation in 
apoptotic cells was performed with a TUNEL assay 
using an ApopTag peroxidase Kit (MP Biomedicals, 
Illkirch, France). Collagen fibril deposition was 
detected with Sirius red staining.  
Microscopy analyses were performed on a Zeiss 
Axioplan 2 Imaging fluorescence microscope (Carl 
Zeiss Microimaging, Göttingen, Germany) or on a 
Leica SP2 AOBS confocal laser-scanning 
microscope (Leica Microsystems, Wetzlar, 
Germany), using the appropriate settings. Image 
stacks of optical sections were further processed 
using the Huygens deconvolution software package 
version 2.7 (Scientific Volume Imaging, Hilversum, 
NL).  
Biochemical analysis of blood 
For determination of pancreatic enzymes present in 
the serum, blood was sampled by heart puncture. 
Blood cells were precipitated by immediate 
centrifugation and amylase and lipase levels were 
measured using the Cobas c111 
spectrophotometer (Roche Diagnostic GmbH, 
Mannheim, Germany).  
Transcript analysis 
The following Taqman probes (Applied Biosystems) 
were used: p53 (Trp53) Mm01731287_m1, p27 
(Cdkn1b) Mm00438168_m1, p15 (Cdkn2b) 
Mm00483241_m1, p16 (Cdkn2a) 
Mm00494449_m1, p19 (Cdkn2d) 
Mm00486943_m1, Mist1 Mm00487695_m1, Sox-9 
Mm00448840_m1, Hes-1 Mm01342805_m1, 
Notch1 Mm00435249_m1, Ccna2 (Cyclin A2) 
Mm00438064_m1, Ccnb2 (Cyclin B2) 
Mm01171453_m1, Ccnd1 (Cyclin D1) 
Mm00432359_m1, Ccne1 (Cyclin E1) 
Mm00432367_m1, Cdc25a Mm00486880_m1, 
Cdc25b Mm00499136_m1, Cdc25c 
Mm00483162_m1, CCKaR Mm00438060_m1, 
TGFβ1 Mm00441724_m1, TGFβR2 
Mm00436977_m1, Wee1 Mm00494175_m1, 
Pkmyt1 Mm01309244_m1 IL-1b Mm00434228_m1, 
MCP-1 Mm00441242_m1, IL-6 Mm00446190_m1, 
cox-1 Mm00477214_m1, cox-2 Mm00478374_m1, 
amy Mm00651524_m1. 
Western blotting 
Immunoblotting was performed by homogenizing 
tissue samples in RIPA buffer containing protease 
inhibitor cocktail (Roche Diagnostics, Mannheim, 
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Germany). Protein concentrations were determined 
using a Bradford protein assay (BioRad, Hercules, 
CA, USA). Aliquots corresponding to 20 or 40 µg of 
proteins were separated by SDS-PAGE 
electrophoresis. Blotting and chemiluminescent 
detection of immunoreactive bands were performed 
using the V3 Western Workflow system (BioRad, 
Hercules, CA, USA), according to the manufacturer 
protocols. Primary antibodies (rabbit anti-sox9 
(Millipore, Massachusetts, USA), rabbit anti-
amylase, rabbit anti-β-catenin (Cell Signaling, 
Danvers, USA), rabbit anti-cleaved caspase-3 (Cell 
Signaling, Danvers, USA), rabbit anti-LC3B (Cell 
Signaling, Danvers, USA),  rabbit anti-β-actin 
(Sigma-Aldrich, Buchs, Switzerland), rabbit anti-
GAPDH (Santa Cruz, Santa Cruz, USA) were 
incubated overnight at 4oC.  
Statistical analyses 
Groups of 5 animals were tested for each 
experiment. The data are expressed as the means 
± SEM. The statistical significance of differences in 
the means of experimental groups was determined 
using an unpaired, two-tailed Student's t test or 
one-way analysis of variance (GraphPad Prism 
4.0c; GraphPad Software, Inc.), and a probability 
value <0.05 was considered statistically significant. 
When the overall probability value was <0.05, the 
Dunnett multiple-comparisons test was used as a 
post-test to determine whether there was a 
significant difference between values of control 
(reference sample) and samples of interest.  
Figure legends 
Figure S1. A. Immunostaining of p21 in WT mice 
after 7 days of cerulein treatment. Arrows show 
interstitial cells with elongated nuclei negative for 
p21. Incubation with secondary antibody alone was 
used as a negative control. B. qPCR of Mist1 and 
amylase during the indicated time of cerulein-
induced pancreatitis. Results are average ± SEM 
(n=5), *p<0.05. Scale bars: 50 µM.   
Figure S2. Serum levels of amylase (A) and lipase 
(B) during cerulein treatment. C. qPCR of CCK 
receptor A during the indicated time of cerulein-
induced pancreatitis. D. Hematoxylin-Eosin (H&E)-
stained sections of pancreata at the indicated time 
of cerulein treatment. Results are average ± SEM 
(n=5), *p<0.05. Scale bars: 50 µM.   
Figure S3. A. TUNEL staining of apoptotic cells 
during the indicated time of cerulein-induced 
pancreatitis. Immunoblotting for cleaved caspase 3 
(B) and LC3-II (C) at the indicated time of 
pancreatitis induction. 40 µg proteins were 
processed for Western blotting and band intensity 
was normalized using GAPDH as a loading control. 
D. Immunostaining of the autophagic marker p62. 
E. Pan-leucocyte immunostaining with anti-coronin-
1. F. Quantification of PU.1 positive myeloid cells, 
including neutrophils and macrophages, at the 
indicated time of cerulein-induced pancreatitis. 
Results are average ± SEM (n=5), *p<0.05. Scale 
bars: 50 µM.   
Figure S4. A. Immunostaining of p21 in WT and 
p21-/- mice after 7 days of cerulein treatment. I, 
islet. B. Immunostaining of Sox9, αSMA and pan-
leucocytes in serial sections from WT and p21-/- 
mice after 7 days of cerulein treatment. C. qPCR of 
progenitor-cell markers during the indicated times 
of cerulein-induced pancreatitis. D. Immunostaining 
(upper panel) and quantification of Sox9 in acinar 
(Ac) and interstitial (Int) cells (lower panel) showed 
a tendency of up-regulation of the protein in intact 
acini in p21-/- mice. Results are average ± SEM 
(n=5), *p<0.05.  
Figure S5. A. qPCR of Cdc25B and Cdc25A during 
cerulein treatment. Results are average ± SEM 
(n=5). B. Co-localization analysis of Ki67 and p21 
in the nuclei of WT pancreata after 7 days of 
cerulein treatment. Arrows indicate nuclei in the 
replicative state expressing p21. C. Co-localization 
analysis of amylase and p21 in WT pancreata after 
7 days of cerulein treatment. Arrows indicate acinar 
cell expression of p21. Scale bars: 30 µM.   
Figure S6. A. Immunostaining of Ki67, PCNA and 
phospho-histone 3 (pH3) during cerulein treatment. 
B. Quantification of pH3 positive pancreatic acinar 
(Ac) and interstitial (Int) cells showed comparable 
proliferation rate in WT and p21-/- mice. Scale bars: 
50 µM.  
Figure S7. A. Hematoxilin/eosin (H&E) and 
Masson’s trichrome staining of WT and p21-/- 
pancreata after a week of recovery following one 
week of cerulein treatment. Quantification of 
amylase activity in pancreatic tissues (B) and sera 
(C) of WT and p21-/- mice after 7 days of recovery 
time. D. Immunostaining of the autophagy marker 
p62 in WT and p21-/- pancreata after a week of 
recovery following one week of cerulein treatment. 
Results are average ± SEM (n>5), *p<0.05. Scale 
bars: 30 µM. 
Figure S8. A. Immunolocalization of β-catenin and 
p21 in AR42J cells. Nuclei are stained with DAPI. 
B. Left panel, immunostaining of p21 (upper row) or 
live imaging (lower row) of AR42J cells infected 
with adenoviruses expressing p21 (Adp21) or GFP 
(AdGFP). Nuclei are stained with DAPI (blue). Note 
the nuclear and cytosolic localization of p21 and 
GFP, respectively. Right panel, densitometric 
quantification after Western blotting of β-catenin 
/GAPDH levels following incubation for 24 h with 
Adp21 or AdGFP. Results are average ± SEM 
(n=3). C. Quantification of trypan blue–positive cells 
after infection with Adp21 at the indicated 
multiplicity of infection (MOI). AdGFP at 100 MOI 
was used as control. Data are average of 
percentage of total cell number (TOT) ± SEM (n=3).  
D. qPCR of p53 in WT and p21-/- mice during 
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cerulein treatment. Results are average ± SEM 
(n=5). Scale bars: 50 µM. 
Figure S9. A. γH2AX immunostaining in ADM 
areas of p21-/- mice after 7 days of cerulein 
treatment. B. Immunostaining of p16 showing 
expression of the protein in intact acini of p21-/- 
mice after 7 days of cerulein treatment. Asterisks 
indicate ADM areas. C. qPCR showed increased 
expression of p27 transcripts in p21-/- mice after 7 
days of cerulein treatment. D. qPCR of cyclin 
B/Cdk1 inhibitors Wee1 and Myt1 during cerulein 
treatment. Results are average ± SEM (n=5), 
*p<0.05. Scale bars: 50 µM.  
Figure S10. Inflammatory response is stimulated in 
the absence of p21. qPCR of pro-inflammatory 
markers (A) and pan-leucocyte immunostaining 
with anti-coronin-1 (B) showed increased 
inflammation in p21-/- mice 7 days after induction of 
pancreatitis. Results are average ± SEM (n=5), 
*p<0.05. Scale bars: 50 µM. 
Figure S11. A, B. Quantification of Sirius red 
staining, expressed as percentage of total field 
area, showed comparable collagen deposition in 
WT and p21-/- mice. C. Similarly, immunostaining of 
α-SMA showed comparable activation of stellate 
cells in the two mouse strains. Results are average 
± SEM (n=5). Scale bars: 50 µM. 
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Abstract 
Determination of signaling pathways that regulate 
pancreatic regeneration following pancreatitis is 
critical for implementing therapeutic interventions. 
In this study we elucidated the molecular 
mechanisms underlying the effects of 
transforming growth factor-β (TGF-β) in pancreatic 
epithelial cells during tissue regeneration. To this 
aim, we conditionally inactivated TGF-β receptor II 
(TGF-β RII) using a Cre/loxP system, under 
control of pancreas transcription factor 1a 
(PTF1a) promoter specific for the pancreatic 
epithelium, and evaluated the molecular and 
cellular changes in a mouse model of cerulein-
induced pancreatitis. We showed that TGF-β RII 
signaling does not mediate the initial acinar cell 
damage observed at the onset of pancreatitis. 
However, we found that TGF-β RII signaling limits 
both acinar cell replication and ADM formation 
during the regenerative phase of the disease. 
Analyses of molecular mechanisms underlying the 
observed phenotype revealed that TGF-β RII 
signaling stimulates the expression of the cyclin-
dependent kinase inhibitor p16 and intersects with 
the EGFR signaling axis. Finally, TGF-β RII 
ablation in epithelial cells resulted in increased 
infiltration of inflammatory cells in the early 
phases of pancreatitis and increased activation of 
pancreatic stellate cells in the later stages of 
pancreatitis, thus highlighting a TGF-β-based 
cross talk between epithelial and stromal cells 
regulating the development of pancreatic 
inflammation and fibrosis.  Collectively, our data 
not only contribute to clarify the cellular processes 
governing pancreatic tissue regeneration, but also 
emphasize the conserved role that TGF-β plays 
as a tumor suppressor both in the regenerative 
process following pancreatitis and in the initial 
phases of pancreatic cancer.  
Introduction 
Repair of pancreatic tissue is observed following 
pancreatitis, an acute or chronic inflammation of 
the exocrine pancreas that continues to be a 
clinical challenge with potentially lethal outcome 
[1]. Transforming growth factor-β (TGF-β) plays an 
essential role in tissue repair and elevated 
expression of this molecule has been documented 
in human pancreatic tissue samples during 
pancreatitis [2, 3]. In addition, studies using rodent 
models of the disease demonstrated that TGF-β 
regulates tissue repair by promoting extracellular 
matrix remodeling and fibrogenesis [4, 5, 6, 7, 8, 
9], thus causally linking  TGF-β signalling to the 
pathophysiology of pancreatitis.  
TGF-β receptor II (TGF-β RII) is a central 
component of the TGF-β signaling pathway, which 
couples ligand binding to downstream activation 
of intracellular Smads  and transcription of target 
genes (recently reviewed in [10]). In previous 
studies, the role of TGF-β RII in the development 
of pancreatitis was investigated by expressing a 
dominant-negative mutant form of the receptor 
under control of metallothionein 1 (MT1) [11, 12] 
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or pS2 mouse trefoil peptide promoters [13]. 
However, these transgenic models delivered 
conflicting results regarding the role of TGF-β 
signaling in the development of pancreatitis.  
Furthermore, these mice exhibited immunological 
and molecular alterations in the pancreas under 
untreated control conditions, suggesting that the 
overexpression of dominant-negative TGF-β RII 
may also affect the functionality of non-epithelial 
pancreatic cells, including immune and stromal 
cells.  
In this study, we aimed to clarify in more detail 
how TGF-β signaling elicited in pancreatic 
epithelial cells contributes to three key phases of 
pancreatitis, namely i) onset of the initial acute 
inflammation, ii) proliferation of acinar cells and iii) 
development of tissue fibrosis. To overcome the 
limitations associated with  the expression of 
dominant-negative TGF-β RII, we generated a 
conditional knockout allele of the receptor by 
crossing TGF-β RIIlox homozygous mice [14] to 
Ptf1a-Cre transgenic animals. This transgenic 
model exhibits functional inactivation of TGF-β 
signaling in pancreatic epithelial cells, without the 
molecular alterations observed in the previous 
dominant negative models. As a result, this model 
allows us to dissect the function of TGF-β 
signalling in these cell types during the distinct 
phases of the disease. 
Material and methods 
Animal experiments 
All animal experiments were performed in 
accordance with Swiss federal animal regulations 
and approved by the cantonal veterinary office of 
Zurich. Transgenic mice expressing TGF-β 
receptor IIflox/flox [15] and mice harboring pancreas 
transcription factor 1a (PTF1a) promoter cre 
transgene (PTF1acre) (MMRRC, USA) were bred 
to generate PTF1acre/TGF-β RII flox/flox (TGF-β RII 
KO) mice. The CRE-negative littermates were 
used as controls and showed no difference from 
TGF-β RII flox/flox mice (not shown). Pancreatitis 
was induced in adult (8-10 weeks of age) male 
mice via six intra peritoneal (i.p.) injections of 50 
µg/kg cerulein administered hourly every second 
day over a two week period, as previously 
described [16]. Control animals received 0.9% 
NaCl injections.   
Histology, immunohistochemistry and 
immunoblotting 
Detailed protocols and primary antibodies used in 
this study are listed in Supplementary Materials 
and Methods. Quantification of labelled cells was 
performed in at least 10 randomly selected high-
power fields (×100) per slide. Non-acinar tissue 
areas (islets, vessels, fibrotic tissue) were 
excluded from the analysis. 
Transcript analysis 
Total RNA was extracted from pancreata as 
previously described [17]. Transcript levels were 
normalized using 18S rRNA as a reference and 
expressed as fold regulation relative to the value 
of untreated control animals, set as one. Taqman 
probes (Applied Biosystems) used in this study 
are listed in Supplementary Materials and 
Methods. 
Results 
Conditional TGFβRII KO mice show normal 
pancreatic development and function 
Ptf1acre/+;Tgf-β RIIflox/flox mice with selective TGF-
β RII ablation in pancreatic epithelial cells 
(designated as TGF-β RII KO) were born at the 
expected frequency, similarly to control 
Ptf1a+/+;Tgf-β RIIflox/flox animals (designed as 
control) or Ptf1acre/+;Tgf-β RII+/+. Confirmation of 
TGF-β RII deletion was obtained by PCR on 
whole pancreas using a primer pair designed 
according to [15] to amplify a 692 base pair 
fragment after successful recombination (Fig. 1A). 
Eight week old TGF-β RII KO mice showed 
normal pancreatic histology, with acinar 
architecture (Fig. 1B) and amylase content (Fig. 
1C) comparable to control animals. Ptf1a-driven 
Cre recombination results in knock out of TGF-
β RII also in pancreatic islets [18]. No 
abnormalities were observed in these structures 
and endocrine parameters including islet size (Fig. 
1D), insulin-containing β cells (Fig. S1A) and 
serum levels of glucose (Fig. 1E) were 
comparable to control mice. In addition, TGF-β RII 
KO mice monitored for 18 months did not show 
morphological alterations in the pancreas [19]. Of 
note, mice expressing a dominant negative form 
of TGF-β RII under the control of a 
methallothionein or pS2 promoters showed higher 
levels of TGFβ isoform 1 and 3 [11, 12], 
inflammatory cells [11] and pro-inflammatory 
cytokines [13] than control mice.  Contrary to 
these results, the described parameters were 
comparable in the pancreas of control and TGF-
β RII KO mice, as assessed by quantification of 
TGF-β isoform levels (Fig. 1F), pan-leukocyte 
staining (Fig. 1G) and expression of pro-
inflammatory cytokines INF-γ, IL-6 and 
macrophage marker F4/80 (Fig. 1H, S1B). Taken 
together, these data indicate that lack of TGF-
β RII in pancreatic epithelia does not compromise 
normal pancreatic development and physiology.  
Conditional TGF-β RII KO mice show 
comparable enzymemia but increased 
inflammatory infiltrates following cerulein-
induced pancreatitis 
The role of TGF-β signalling during the acute 
phase of pancreatic inflammation is still 
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controversial, as pancreatic overexpression of a 
dominant negative form of TGF-β RII has been 
reported to either exacerbate [13] or attenuate 
[11] cerulein-induced acute pancreatitis, reflected 
by increased or decreased serum levels of 
amylase and lipase, respectively. To clarify these 
contradictory results, we evaluated the severity of 
acute pancreatitis in control and TGF-β RII KO 
mice. Following cerulein treatment, the two strains 
displayed similar pancreatic morphology (Fig. 2A) 
and comparable serum levels of amylase and 
lipase, early indicators of acinar cell damage (Fig. 
2B). Serum levels of liver alanine 
aminotransferase, which are reported to slightly 
increase after cerulein treatment [20], were also 
comparable in the two strains (Fig. 2C). In 
addition, acinar trypsinogen was activated 
following pancreatitis and the level of activation 
was not statistically different in the two strains, 
even if TGF-β RII KO mice showed a trend of 
lower activation compared with the control 
animals (Fig. 2D). TGF-β RII KO mice had more 
apoptotic acinar cells than control animals 8 hours 
after treatment (Fig. 2E), but the number of 
apoptotic cells accounted for less than two 
percent of the total number of acinar cells (Fig. 
S2A), indicating that apoptosis is not greatly 
induced in the absence of TGF-β signalling. The 
attenuation of cerulein-induced pancreatitis 
reported in mice with dominant negative TGF-
β RII expression was linked to CCK/cerulein 
resistance and up-regulation of CCK-A receptor 
both in untreated condition and upon cerulein 
stimulation [11]. Contrary to these results, TGF-
β RII KO and control mice showed comparable 
levels of CCK-A (Fig. 2F) and B (Fig. S2B) 
receptors both in untreated conditions and 
following cerulein treatment, thus indicating that 
TGF-β signaling is not required to modulate 
mRNA expression of CCK-A/B receptors. In 
addition, the previously described mice 
expressing dominant negative TGF-β RII showed 
higher levels of pancreatic inflammation under 
untreated condition. However, inflammation levels 
did not further increase during the development of 
pancreatitis and were similar to the increased 
levels observed in control mice after cerulein 
treatment [11, 13]. On the contrary, despite the 
comparable enzymemia and tissue morphology 
observed in control and TGF-β RII KO mice, 
immunostaining showed more infiltration of 
leukocytes (Fig. 2G) and macrophages (Fig. S2C) 
in TGF-β RII KO one day after the beginning of 
cerulein treatment. Similarly, enumeration of PU.1 
positive myeloid cells, including neutrophils and 
macrophages, confirmed the increased infiltration 
in the first day of treatment, while infiltrate levels 
and cytokine expression were comparable in the 
two strains at the later time points of the treatment 
(Fig. 2H, S2D). These data indicate that lack of 
TGF-β signalling in epithelial cells did not 
exacerbate acinar cell damage during cerulein 
treatment. However, it resulted in a transient 
increase in immune cell infiltration during the 
acute phase of pancreatitis.  
Conditional TGF-β RII KO mice show increased 
cell cycle entry following cerulein-induced 
pancreatitis  
TGF-β is a negative regulator of cell cycle 
progression inducing cell cycle arrest in both 
G0/G1 and G2/M phases [21]. As TGF-β RII is up-
regulated in the pancreas of control mice during 
pancreatitis (Fig. S3A), we evaluated whether lack 
of TGF-β RII in epithelial cells was associated with 
increased levels of acinar replication following 
induction of the disease. Ablation of canonical 
TGF-β signalling in TGF-β RII KO mice was 
further confirmed by reduced phosphorylation of 
Smad2 and Smad3, which are triggered 
downstream of TGF-β RII activation (Fig. S3B). In 
untreated conditions, TGF-β RII KO mice did not 
show spontaneous activation of the cell cycle in 
epithelial cells (Fig. 3A). However, after one week 
of cerulein treatment, these mice had more 
replicating acinar cells than control animals, as 
shown by Ki67 and Bromodeoxyuridine (BrdU) 
staining (Fig. 3A, S3C). The mitotic marker 
phosphor-histone 3 (pH3) showed increased 
expression but without reaching statistical 
significance (Fig. S3C). Importantly, the number of 
replicating interstitial cells increased in a 
comparable manner in the two strains (Fig. S3D), 
while cerulein treatment did not induce 
proliferation of ductal and islet cells (Fig. S3D), 
indicating that ablation of TGF-β RII in pancreatic 
epithelia increased cell cycle entry exclusively in 
acinar cells following induction of pancreatitis.  
TGF-β signalling can limit cell cycle progression 
by inducing the expression of cyclin-dependent 
kinase (Cdk) inhibitors [22]. We then tested 
whether increased acinar replication in TGF-β RII 
KO mice was associated with lower Cdk inhibitor 
expression. Indeed, after one week of cerulein 
treatment, TGF-β RII KO pancreata showed lower 
expression of p16 in the nuclei of acinar cells, 
while the staining in interstitial cells was similar in 
the two strains (Fig. 3B).  A trend of lower p16 
levels was also evident at the transcript level (Fig. 
S4). Expression of p21 and p27 was comparable 
in the two mouse strains (Fig. S3F). TGF-β 
signalling can also limit cell cycle progression by 
inducing apoptosis (reviewed in [23]). However, 
the number of TUNEL positive apoptotic cells was 
comparable in both strains after three and seven 
days of cerulein treatment (Fig. 3C), suggesting 
that the increased replication observed in the 
absence of TGF-β RII is not derived from 
decreased apoptosis of acinar cells, but rather 
from limited expression of the cyclin-dependent 
kinase inhibitor p16. 
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Conditional TGF-β RII KO mice show increased 
ADM formation following cerulein-induced 
pancreatitis  
Next, we evaluated whether lack of TGF-β 
signalling in epithelial cells affects the formation of 
acinar-to-ductal metaplasia (ADM), a transient 
trans-differentiation of acinar cells observed 
during pancreatic regeneration. The percentage of 
mice showing ADM formation was higher in TGF-
β RII KO mice after three and seven days of 
cerulein treatment (Fig. 4A) and the lesions were 
bigger three days after the treatment (Fig. 4B). 
ADM lesions showed down-regulation of amylase 
content and higher number of apoptotic cells 
compared with intact acini, while the level of Ki67 
positive cells was similar to the surrounding intact 
tissue (Fig. 4C). As we detected increased ADM 
formation in TGF-β RII KO mice, we investigated 
whether factors promoting ADM are activated in 
the absence of epithelial TGF-β signalling. Cells 
undergoing ADM in TGF-β RII KO mice showed 
high levels of active phosphorylated epidermal 
growth factor receptor (EGFR) (Fig. 4D), a critical 
inducer of ADM formation [24]. Altogether, these 
results indicate that TGF-β signalling in epithelial 
cells limits ADM formation following cerulein-
induced pancreatitis. 
Lack of TGF-β RII results in increased 
pancreatic fibrosis 
Several reports highlighted the importance of 
TGF-β signalling for the development of fibrosis in 
the pancreas (reviewed in [6]). However, some 
controversy still remains, as pancreatic 
expression of dominant negative TGF-β RII under 
control of the MT1 or pS2/TFF1 promoters either 
increased [12] or reduced [9] pancreatic fibrosis, 
respectively. Thus, we assessed the level of 
fibrosis in TGF-β RII KO animals during 
pancreatitis. TGF- β RII KO pancreata showed 
higher expression levels of αSMA (Fig. 5A) and 
enhanced Sirius red staining (Fig. 5B), which 
indicate increased activation of stellate cells and 
collagen deposition in these mice. To understand 
the mechanism by which ablation of TGF-
β signalling in epithelial cells led to increased 
activation of stromal stellate cells, we evaluated 
whether the absence of TGF- β RII resulted in a 
compensatory increase of TGF-β levels, a potent 
activator of stellate cells. Quantification of TGF-β 
in pancreata, by qPCR, (Fig. S5A) and western 
blotting (Fig. S5B), and in blood, by ELISA assay 
(Fig. S5C), showed comparable levels of TGF-β in 
the two strains, indicating that the increased 
fibrosis observed in TGF-β RII KO mice is not a 
consequence of increased TGF-β expression. 
Then we tested whether TGF-β activators 
increased in TGF- β KO RII mice. An important 
activator of TGF-β is the αν subunit of 
transmembrane integrins that binds and activates 
latent TGF-β stored in the extracellular matrix 
(recently reviewed in [25]). Our analyses focussed 
on the ανβ6 isoform, as its deletion or 
pharmacological inhibition was sufficient to 
prevent latent TGF-β1 activation in pancreas [26] 
and lung [27, 28]. ανβ6 integrin was up-regulated 
during the development of pancreatitis and was 
localized on acinar cell membrane and ADM 
areas (Fig.5C). However, its expression was 
similar in control and TGF-β RII KO mice, 
indicating that lack of TGF-β receptor does not 
result in compensatory up-regulation of ανβ6 
integrin and increased TGF-β activation. Finally, 
we analyzed whether pro-fibrotic cytokines [29] 
were elevated in TGF-β RII KO mice. We did not 
observe any difference in the transcript levels of 
CXCL1, CXCL2, CXCL16 and IGF-1 (Fig. S6). 
Collectively, these data indicate that lack of TGF-β 
receptor in pancreatic epithelial cells is sufficient 
to increase the fibrotic response during 
pancreatitis without increasing the expression of 
its ligand TGF-β or pro-fibrotic factors.  
Discussion 
In this study, we demonstrated that TGF-β 
signaling in epithelial cells is dispensable for the 
development of the adult pancreas. During onset 
of acute pancreatitis, this pathway does not 
appear to influence acinar damage, while in the 
progression of the disease it is required to 
constrain acinar cell replication and development 
of acinar-to-ductal metaplasia. 
The main advantage of our TGF-β RII knock-out 
model, compared with the overexpression of a 
dominant negative TGF-β RII mutants used 
previously [11, 12, 13], consists in the absence of 
immunological and molecular alterations under 
untreated conditions. This different phenotype can 
be explained by the specificity of the promoters 
used as the Ptf1a-Cre transgene is selective for 
the pancreas, while MT1 or pS2 promoters are 
active also in extra-pancreatic tissues [12, 13] and 
may affect systemic responses. Furthermore, non-
physiological gain-of-function activities elicited by 
ectopically overexpressed proteins may contribute 
to the baseline alterations observed in the 
previous studies.  Thus, our TGF-β RII KO model 
with normal phenotype under untreated conditions 
allows the characterization of TGF-β signaling 
during pancreatitis induced upon cerulein 
treatment.   
TGF-β receptor II and acute pancreatitis 
The role of TGF-β receptor in the early phases of 
cerulein-induced pancreatitis has been examined 
in two previous studies using dominant negative 
mutants of the TGF-β receptor II under control of 
MT1 or pS2 promoters. These reports reached 
opposite conclusions on the role of TGF-β 
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receptor, as its dominant negative form either 
exacerbated [13] or reduced [11] the severity of 
pancreatitis. Importantly, despite the opposite 
disease outcome, even under untreated 
conditions both these mutants showed higher 
levels of pancreatic inflammation, which did not 
further increase following cerulein treatment. As 
discussed in these studies, the presence of 
inflammatory infiltrates under untreated conditions 
may be attributable to the presence of mutant 
TGF-β receptor II not only in acinar cells but also 
in inflammatory cells. Thus, these models are not 
suitable to dissect the selective contribution of 
TGF-β signaling derived from parenchymal and 
inflammatory cell types. Nevertheless, these 
studies highlight the intriguing concept that the 
level of inflammation per se does not directly 
correlate with the damage of acinar cells and the 
severity of pancreatitis. In our TGF-β RII KO 
model we observed that the most sensitive 
parameter to determine acinar cell damage, 
namely, release of amylase and lipase into the 
blood, was comparable to control animals. 
Likewise, the two strains showed similar 
expression of CCK receptors and morphological 
appearance, suggesting that TGF-β signalling in 
epithelial cells does not regulate the severity of 
acinar cell damage. However, we observed 
increased numbers of infiltrating cells in TGF-β RII 
KO mice one day after induction of pancreatitis. 
This apparent conundrum of an effect observed in 
non-parenchymal inflammatory cells following 
ablation of TGF-β receptor II in parenchymal cells 
is similar to what we observed in regards to 
development of fibrosis at later stages of the 
disease. For this reason, we will discuss the 
potential mechanisms underlying these 
phenotypes in the paragraph dedicated to fibrosis. 
TGF-β receptor II and pancreatic regeneration 
Earlier reports showed that acinar cell replication 
is inhibited by TGF-β overexpression in the 
pancreas or by TGF-β administration to pancreatic 
explants [4, 30, 31, 32], indicating that acinar cells 
are responsive to TGF-β signalling. Further 
studies showed that overexpression of a dominant 
negative TGF-β RII in the pancreas is sufficient to 
increase the proliferation of acinar cells in the 
absence of a regenerative stimulus [12]. However, 
this study was complicated by the fact that the 
transgenic mice presented spontaneous 
inflammation and elevated TGF-β levels [11, 12], 
thus raising the question whether the increased 
acinar replication could have been triggered by 
factors released by TGF-β-stimulated non-acinar 
cells. Indeed, acinar replication was not increased 
in our TGF-β RII KO untreated mice, which did not 
have increased inflammation or TGF-β levels. 
This suggests that TGF-β RII signalling is not 
required for homeostatic turnover of acinar cells in 
the absence of cell injury. Following pancreatitis, 
on the other hand, absence of TGF-β RII resulted 
in an increased rate of replication exclusively in 
acinar and not in other epithelial or interstitial 
cells, suggesting a specific inhibition of acinar 
replication upon an inflammatory insult via TGF-β 
RII signalling via up-regulation of the cyclin-
dependent kinase inhibitor p16. This is in marked 
contrast to what observed in pancreatic β-cell 
where TGF-β RII signaling promoted β-cell 
replication following pancreatic duct ligation [18]. 
Conversely, the same authors and [33] showed 
that TGF-β RII signaling inhibited β-cell replication 
following partial pancreatectomy, further 
supporting the concept that TGF-β regulates 
cellular replication in a cell type and context 
dependent manner. These alternating growth-
inhibitory and growth-promoting effects of TGF-β  
are of particular importance during pancreatic 
tumorigenesis where TGF-β converts over time 
from a tumor suppressor to a mitogen that 
enhances cancer progression [34, 35]. 
Of note, we found that the number of acinar cells 
positive for phosphor-histone 3, a marker of M 
phase not evaluated in previous studies, was 
comparable in the two strains. This suggests that, 
despite increased cell cycle entry in the absence 
of TGF-β RII, compensatory mechanisms may be 
activated to limit the completion of acinar cell 
division. 
In addition, we observed that lack of TGF-β RII 
was also associated with increased formation of 
ADM during the course of pancreatitis. 
Spontaneous ADM formation was also observed 
in mice expressing a dominant negative TGF-β RII 
[12] and in mice with disrupted TGF-β signaling 
following overexpression of the inhibitory Smad7 
under control of an elastase promoter [36]. 
Unexpectedly, Smad7 overexpression reduced 
ADM formation triggered by cerulein-induced 
pancreatitis [37]. While the molecular mechanisms 
responsible for these discordant phenotypes are 
not clear, they may result from context-dependent 
integration of different signaling pathways, as 
Smad7 inhibits both the TGF-β and the BMP 
branches of the TGF-β family signaling pathways. 
Our analyses elucidated the molecular 
mechanisms that are regulated in vivo by TGF-β 
signalling during the course of pancreatitis. 
Specifically, we found increased activation of 
EGFR, a potent inducer of ADM formation and 
malignant transformation [38], in the absence of 
TGF-β RII, suggesting that TGF-β exerts an 
inhibitory effect on the EGFR signaling in acinar 
cells. A similar antagonistic role of TGF-β RII and 
EGFR signalling has recently been reported in 
regulating the replication of β-cells following 
pancreatic duct ligation [39], raising the intriguing 
possibility that a TGF-β/EGFR cross-talk is 
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intrinsic to pancreatic regeneration. The question 
then arises as to whether the observed TGF-β 
intersection with the EGFR signalling is at the 
base of the tumor suppressor role of TGF-β in 
pancreatic cancer. While further studies are 
required to unequivocally demonstrate this 
concept in vivo, previous reports showed that 
ablation of TGF-β  signalling by loss of Smad4 
increased the expression of EGFR in pancreatic 
cancer cells in vitro [40, 41]. In addition, loss of 
TGF-β RII was associated with higher EGFR 
levels and more aggressive and metastatic tumors 
in pancreatic ductal adenocarcinoma [19] and 
head-and-neck squamous cell carcinoma in vivo 
[42]. Thus, it is tempting to speculate that TGF-β-
mediated inhibition of EGFR signaling may be an 
early conserved molecular mechanism to 
counteract tumorigenesis, both during 
regeneration and malignant transformation. 
Conversely, at later stages of cancer progression, 
TGF-β/EGFR signaling can develop in a 
synergistic mode, as previously shown [43, 44, 
45], and thus contribute to the tumor supporting 
function of TGF-β. 
TGF-β receptor II and development of fibrosis  
An unexpected result of our study was the 
increased collagen deposition in TGF-β RII KO 
mice. The elevated expression of αSMA suggests 
that stellate cell activation into fibrogenic 
myofibroblasts actively contributes to the 
enhanced stromal reaction. This phenotype 
observed in non-parenchymal cells following 
ablation of TGF-β receptor II in parenchymal cells 
resembles the increased inflammation detected 
during the acute phase of pancreatitis and 
suggests the existence of a complex and tightly 
regulated balance between epithelial and non-
epithelial cells during the development of 
pancreatitis. To identify the molecular 
mechanisms at the base of the increased 
inflammation and fibrosis, we evaluated whether 
ablation of TGF-β receptor resulted in a 
compensatory increase of TGF-β, as increased 
TGF-β levels were reported in mice expressing a 
dominant negative TGF-β RII [12]. TGF-β, acting 
together with other co-stimulatory molecules, is a 
very potent regulator of both immune response 
and fibrogenic processes. In particular, TGF-β1 
stimulates chemotaxis of monocytes and 
neutrophils, the major leukocyte populations that 
are recruited in the pancreas during pancreatitis. 
While exerting a pro-inflammatory function in 
monocytes, TGF-β1 has also an anti-inflammatory 
effect in monocytes after their differentiation into 
macrophages.  This, together with similar effects 
on other inflammatory cell types (reviewed in 
[46]), support a dual role of TGF-β1 in the control 
of inflammation, namely via promoting the 
initiation of the process and contributing to its 
resolution. This time-dependent regulatory activity 
of TGF-β1 would be consistent with what we 
observed in TGF-β RII KO mice where the 
increased inflammation was transient and limited 
to the first day following induction of pancreatitis. 
In addition, TGF-β  is a potent activator of stellate 
cells, key players in pancreatic fibrosis following 
pancreatitis (recently reviewed in [47]). Thus, 
increased levels of TGF-β could explain the 
increased inflammatory and fibrotic processes 
observed in TGF-β RII KO mice. However, 
quantitative analyses of pancreatic and circulating 
levels of TGF-β showed similar expression in the 
two strains. This indicates that increased 
inflammation and fibrosis do not result from 
increased TGF-β production and that ablation of 
TGF-β receptor in epithelial cells does not result in 
a compensatory up-regulation of its ligand. In this 
context, an additional aspect of TGF-β regulation 
can be extrapolated from our results. TGF-β  was 
shown to induce a positive feedback loop in acinar 
cells by stimulating both TGF-β and TGF-β RII 
expression [31]. The fact that ablation of epithelial 
TGF-β  RII did not change  TGF-β  levels in vivo 
suggests that the contribution of epithelial cells to  
produce TGF-β  in the pancreas following 
cerulein-induced pancreatitis is limited. An 
alternative mechanism responsible for the 
observed increased fibrosis is the secretion by 
epithelial cells lacking TGF-β RII of pro-fibrotic 
factors normally down-regulated by TGF-β 
signaling. While seemingly contradictory to the 
pro-fibrotic function of TGF-β, a similar regulation 
has been shown in a transgenic model of 
pancreatic cancer, where TGF-β down-regulated 
the production of pro-fibrotic CXC chemokines in 
epithelial cells [48]. However, pro-fibrotic CXC 
chemokines were not up-regulated in TGF-β RII 
KO mice, suggesting that this pathway is not likely 
to contribute to the observed phenotype. Finally, 
an intriguing explanation for the increased 
inflammation and fibrosis in TGF-β RII KO mice is 
that, despite the unchanged levels of TGF-β in the 
pancreas, this cytokine does not bind to epithelial 
cells due to the lack of its receptor and 
consequently it becomes more available to 
inflammatory and stromal cells, resulting in their 
increased stimulation. Thus, the ability of epithelial 
cells to act as a buffer by binding selected 
cytokines and therefore modulating their 
availability to non-epithelial cells is likely to be a 
critical element in the complex network regulating 
the progression of pancreatic diseases. 
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Figure legends 
Figure 1. Pancreatic development is normal in 
TGF-β RII KO mice. A. Schematic representation 
of the breeding strategy to produce mice with 
TGF-β RII deletion in pancreatic epithelial cells. 
Ptf1acre/+ mice were bred with Tgf-βRIIflox/flox to 
generate Ptf1acre/+;Tgf-βRIIflox/flox mice, named 
TGF-β RII KO. Activation of Cre recombinase in 
PTF1a positive pancreatic cells removes exon 4 in 
TGF-β RII, which is required for recruitment of and 
dimerization with TGF-β RI and consequent 
normal receptor functions. For validation of TGF-β 
RII receptor ablation a primer pair was designed 
to amplify a 692 bp fragment after recombination 
and removal of exon 4 from the TGF-β RII locus. 
RT-PCR was performed on whole pancreas 
samples. B. Hematoxylin-Eosin (H&E)-stained 
sections of untreated control (Cntl) and TGF-β RII 
KO (KO) pancreata showing comparable tissue 
morphology.  C. Amylase activity in untreated 
pancreatic tissue. D. Islet size, expressed as area, 
in untreated pancreatic tissue. E. Blood glucose 
levels in untreated pancreatic tissue. F. qPCR of 
TGF-β isoforms in untreated pancreatic tissue. G. 
Immunostaining of pan-leukocytes in untreated 
pancreatic tissue.  H. qPCR of interferon-γ (INF-γ), 
interleukin 6 (IL6) and macrophage marker F4/80 
in untreated pancreatic tissue. Results are 
average ± SEM (n≥5). Scale bars: 50 µM. 
Figure 2. Onset of pancreatitis in TGF-β RII KO 
mice. A. Pancreatitis was induced in control (Cntl) 
and TGF-β RII KO (KO) mice with six injections of 
50 µg/kg cerulein administered hourly on alternate 
days over a period of one week. The indicated 
times of animal harvest refer to the first cerulein 
injection. Hematoxylin-Eosin (H&E)-stained 
sections of pancreata showing comparable tissue 
morphology after 8 hours and one day of 
pancreatitis induction. B. Serum levels of amylase 
and lipase following cerulein treatment. C. Serum 
levels of alanine aminotransferase (ALT) following 
cerulein treatment. D. Quantification of 
trypsinogen activation following cerulein 
treatment. E. TUNEL staining showing the number 
of apoptotic cells in intact acini following cerulein 
treatment. F. qPCR of CCK receptors A and B 
following cerulein treatment. G. Immunostaining of 
pan-leukocytes after one day of cerulein 
treatment. H. Quantification of PU.1 positive 
myeloid cells infiltrating the pancreas following 
cerulein treatment. Results are average ± SEM 
(n≥5), *p<0.05. Scale bars: 50 µM. 
Figure 3. Acinar cell proliferation does not 
increase in the absence of TGF-β RII. A. 
Immunostaining (left panel) and quantification 
(right panel) of Ki67 positive pancreatic acinar 
cells showed increased proliferation rates in TGF-
β RII KO mice (KO) compared with control mice 
(Cntl) seven days after induction of pancreatitis. 
B. Immunostaining showed lower expression of 
p16 in acinar cells of TGF-β RII KO mice seven 
days after induction of pancreatitis. Arrows in the 
lower panels indicate interstitial cells that express 
similar p16 levels in the two strains. C. TUNEL 
staining (upper panel) and quantification (lower 
panel) showing comparable apoptosis of acinar 
cells in the two strains at the indicated time after 
induction of pancreatitis. Results are average ± 
SEM (n≥5), *p<0.05. Scale bars: 50 µM. 
Figure 4. ADM is enhanced in the absence of 
TGF-β RII. A. Quantification of mice with ADM at 
the indicated times of pancreatitis induction 
showed higher incidence of ADM in TGF-β RII KO 
mice (KO) compared with control mice (Cntl). 
Data are expressed as percentage of the total 
number of mice (n>5). B. Left panel. Hematoxylin-
Eosin (H&E)-stained sections of pancreata three 
days after cerulein treatment showed extended 
regions of ADM (asterisks) in KO mice. Right 
panel. Quantification of ADM area following 
cerulein-induced pancreatitis. Data are normalized 
by the total pancreatic area. C. 
Immunohistochemical analyses of KO mice after 
three days of pancreatitis revealed that, compared 
with the surrounding intact acinar tissue, ADM 
areas (asterisks) were negative for the acinar cell 
marker amylase, had a higher level of apoptotic 
cells (TUNEL) and similar number of replicating 
cells (Ki67). D. Immunostaining of phosphorylated 
EGFR (p-EGFR) showed increased labeling in 
ADM areas after the development of pancreatitis. 
Nuclei are stained with DAPI (blue). Results are 
average ± SEM (n≥5). Scale bars: 50 µM. 
Figure 5. A. Immunostaining (left panel) and 
immunoblotting (right panel) of α-SMA showed 
higher activation of stellate cells in TGF-β RII KO 
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mice (KO) compared with control mice (Cntl). 
40 µg proteins were processed for Western 
blotting and band intensity was normalized using 
GAPDH as a loading control. Results are average 
± SEM (n=3).  B. Similarly, quantification of Sirius 
red staining, expressed as percentage of total 
field area, showed higher collagen deposition in 
KO mice. C. Immunostaining and quantification of 
integrin ανβ6, expressed as percentage of total 
field area. Right panels, representative integrin 
αVβ6 immunostaining three days after induction of 
pancreatitis. Results are average ± SEM (n≥5). 
Scale bars: 50 µM. 
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Supplemental online material 
Materials and Methods 
Pancreatitis induction 
Animals received six hourly injections of 50 µg/kg 
cerulein on alternate days. Animals were treated 
on day 0, day 2 and day 4 and were harvested on 
day one after one set of injections, on day 3 after 
two sets of injections or on day 7 after three sets 
of injections, without cerulein treatment on the 
same day. 
Biochemical analysis of enzyme activity 
For determination of pancreatic enzymes present 
in the serum, blood was sampled by heart 
puncture. For determination of amylase levels 
present in pancreatic tissue, pancreata were 
homogenized with RIPA buffer containing 
protease inhibitor cocktail (complete ultra-tablets 
mini, Roche Diagnostics, Mannheim, Germany). 
Amylase and lipase levels were measured in the 
serum using the FUJIFILM DRI-CHEM 4000i 
analyzer (FIJIFILM Corporation, Tokyo, Japan).  
For trypsinogen activation, 20 mG frozen 
pancreatic tissue was homogenized in 250 µL 
cold MOPS buffer (250 mM sucrose, 5 mM 
MOPS, 1 mM Mg SO4, pH 6.5) using the 
Precellys® 24 tissue homogenizer. Trypsin 
activity was measured flourometrically at 37°C in 
250 µL trypsin assay buffer (50 mM Tris, 150 mM 
NaCl, 1 mM CaCl2, 0.1% BSA, pH 8.0) 
containing 250 µg supernatants and 40µM Boc-
Glu-Ala-Arg-MCA (Bachem, Bubendorf, 
Switzerland) as a substrate, as described [1]. The 
fluorescence emitted at 440 nm in response to 
excitation at 380 nm was monitored over a 10 
min period. 
Immunohistochemistry 
Pancreas specimens were embedded in paraffin 
for histological analyses as described [2]. Primary 
antibodies used in this study were: anti-phospho-
stat3 (Tyr705) (Cell signaling, Massachusetts, 
USA), rabbit anti-TGFβ1 (Santa Cruz 
Biotechnology inc, Santa Cruz, USA), rabbit anti-
TGFβ2 (Santa Cruz Biotechnology inc, Santa 
Cruz, USA), rabbit anti-TGFβ3 (Abcam, 
Cambridge, UK), rabbit anti-phospho-smad2 
(Ser465/467) (Millipore, Massachusetts, USA), 
insulin, rat anti-F4/80 (BMA Biomedicals, Augst, 
Switzerland), mouse anti-integrin αvβ6 (gift from 
Biogen Idec, Inc), rabbit anti-Pu.1 (Cell signaling, 
Massachusetts, USA), rabbit anti-phospho-
histone 3 (Millipore, Massachusetts, USA), 
mouse anti-p21 (BD Pharmingen, NY, USA), 
rabbit anti-p27 (Santa Cruz Biotechnology inc, 
Santa Cruz, USA), mouse anti-αSMA (Dako, 
Glostrup, Denmark), rabbit anti-amylase (Sigma-
Aldrich, Buchs, Switzerland), rabbit anti-coronin-1 
(gift from Jean Pieters), rabbit anti-Ki67 (Abcam, 
Cambridge, UK), rabbit anti-p16 INK4B (Novus 
Biologicals, CO, USA), rabbit anti-Smad2/3 
(Novus Biologicals, CO, USA), rabbit anti-
phospho-Smad3 (Ser423/425) (Cell signaling, 
Massachusetts, USA), rabbit anti-phospho-EGFR 
(Millipore, Massachusetts, USA), rabbit anti-
GAPDH (Sigma-Aldrich, Buchs, Switzerland). 
Secondary antibodies used in this study were: 
Biotinylated Goat Anti-Rabbit IgG (H+L), 
Biotinylated Goat Anti-Mouse IgG (H+L) and 
Biotinylated Goat Anti-Rat IgG (H+L). These 
antibodies are included in the 
VECTASTAIN® ABC kits. AlexaFluor 594 Goat 
Anti-Rabbit IgG, (Life Technologies, Carlsbad, 
California, USA).  
Detection of DNA fragmentation in apoptotic cells 
was performed with a TUNEL assay using an 
ApopTag peroxidase Kit (Millipore, 
Massachusetts, USA). Collagen fibril deposition 
was detected with Sirius red staining. Microscopy 
analyses were performed on a Nikon Eclipse Ti 
fluorescence microscope (Amsterdam, The 
Netherlands).  
Western blotting 
Immunoblotting was performed by homogenizing 
tissue samples in RIPA buffer containing 
protease inhibitor cocktail (Roche Diagnostics, 
Mannheim, Germany). Protein concentrations 
were determined using a Bradford protein assay 
(BioRad, Hercules, CA, USA). Aliquots 
corresponding to 50 µg of proteins were 
separated by SDS-PAGE electrophoresis and 
blotting using a V3 Western Workflow system 
(BioRad, Hercules, CA, USA) according to 
manufacturer protocols. PVDF membranes were 
incubated with primary antibodies overnight at 
4oC. All results were measured by densitometry 
and expressed by relative expression to GAPDH 
as a reference protein. 
Active TGFβ measurement 
Active TGF-β levels were quantified in blood 
serum using DuoSet ELISA kits (R&D Systems), 
in accordance with the manufacturer's 
instructions.  
Genomic DNA extraction and PCR 
Genomic DNA was extracted from pancreas 
tissue using a lysis buffer containing 100 mM 
Tris-HCl pH=8.5, 5 mM EDTA, 0.2% SDS, 200 
mM NaCl, 100 µg proteinase K/ml. The tissue 
was incubated over night at 55 ºC with agitation 
followed by 15 min proteinase K inactivation at 95 
ºC. Mice were genotyped using conventional 
PCR according to manufacturer's instructions 
(Taq PCR Core Kit, Qiagen) with the following 
primer pairs: P1:   5’-GAAGGAAAAGAAAAGGG-
3‘, P2:  5‘-CCAGCACTCGGTCAAAG-3’; P5: 5-
TATTGGGTGTGGTTGTGGACTTTA-3, P3: 5-
TATGGACTGGCTGCTTTTGTATTC-3. P3 and 
P5 primer pair was used to screen for mice 
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containing the null alleles and yielding positive 
692bp PCR product. P1 and P2 primer pair was 
used to screen for TGF-β RII encoding sequence 
between exon 4 and exon 8. The samples where 
exon 4 was intact yielded a 1195bp PCR product. 
Transcript analysis 
The following Taqman probes (Applied 
Biosystems) were used: MCP1 (CCL2) 
Mm00441242_m1, IL-6 Mm00446190_m1, IL-1β 
Mm00434228_m1, p21 (WAF1) 
Mm00432448_m1, p27 (Cdkn1b) 
Mm00438168_m1, p15 (Cdkn2b) 
Mm00483241_m1, p16 (Cdkn2a) 
Mm00494449_m1, TGF-β1 Mm00441724_m1, 
TGF-β2 Mm00436955_m1, TGF-β3 
Mm00436960_m1, EGFR Mm00433023_m1, 
EGF Mm00438696_m1, IGF1 Mm00439560_m1, 
TGF-β RII Mm00436977_m1, F4/80 
Mm00802530_m1, INF-γ Mm01168134_m1, 
CCKAR Mm00438060_m1, CCKBR 
Mm00432329_m1, CXCL1 Mm04207460_m1, 
CXCL2 Mm00436450_m1, CXCL16 
Mm00469712_m1. 
Statistical analyses 
Groups of 5 animals were tested for each 
experiment. The data are expressed as means ± 
SEM. The statistical significance of differences in 
the means of experimental groups was 
determined using an unpaired, two-tailed 
Student's t test or one-way analysis of variance 
(GraphPad Prism 4.0c; GraphPad Software, 
Inc.), and a probability value <0.05 was 
considered statistically significant. When the 
overall probability value was <0.05, the Dunnett 
multiple-comparisons test was used as a post-
test to determine whether there was a significant 
difference between values of control (reference 
sample) and samples of interest.  
Figure legends 
Figure S1. A. Immunostaining of insulin in 
untreated control (Cntl) and TGF-β RII KO (KO) 
mice. B. Immunostaining of macrophage marker 
F4/80 in untreated pancreatic tissue. Scale bars: 
50 µM. 
Figure S2. A. Quantification of TUNEL positive 
acinar cells expressed as percentage of total 
acinar cell number in control (Cntl) and TGF-β RII 
KO (KO) mice eight hours after induction of 
pancreatitis. B. qPCR of CCK-B receptor in Cntl 
and KO pancreata at the indicated time following 
induction of pancreatitis. C. Immunostaining of 
macrophages (F4/80) after pancreatitis induction. 
D. qPCR of interferon-γINF-γ), monocyte 
chemoattractant  protein 1 (MCP1) and  
interleukin 6 (IL-6) in Cntl and KO pancreata at 
the indicated time following induction of 
pancreatitis. Results are average ± SEM (n≥5), 
*p<0.05.  
Figure S3. A. qPCR of TGF-β RII in control mice 
at the indicated time following induction of 
pancreatitis. B. Immunoblotting of 40 µg proteins 
showed up-regulation of phosphorylated Smad3 
and Smad3 in control (Cntl) but not in TGF-β RII 
KO (KO) pancreata following pancreatitis 
induction. Band intensity was normalized using 
GAPDH as a loading control. C. Quantification of 
BrdU and phopsho-histone 3 (pH3) positive 
pancreatic acinar cells in Cntl and KO mice 
seven days after induction of pancreatitis. D. 
Quantification of Ki67 positive interstitial cells at 
the indicated time following induction of 
pancreatitis. E. Immunostaining of Ki67 did not 
reveal increased replication of islet (i), ductal (d) 
and vascular (v) cells in KO mice following 
pancreatitis induction. Three days of treatment 
are shown. F. Immunostaining showed 
comparable expression of p27 and p21 in acinar 
cells of TGF-β RII KO mice seven days after 
induction of pancreatitis. Results are average ± 
SEM (n≥5), *p<0.05. Scale bars: 50 µM. 
Figure S4. qPCR of cyclin-dependent kinase 
inhibitors in control (Cntl) and TGF-β RII KO (KO) 
pancreata at the indicated time following 
induction of pancreatitis. Results are average ± 
SEM (n≥5). 
Figure S5. A. qPCR of TGF-β isoforms in control 
(Cntl) and TGF-β RII KO (KO) pancreata at the 
indicated time following induction of pancreatitis. 
B. Immunoblotting of TGF-β1latent, active dimer 
and monomer forms in Cntl and KO pancreata at 
the indicated time following induction of 
pancreatitis. Band intensity was normalized using 
GAPDH as a loading control. C. Quantification of 
active TGF-β1 dimer in Cntl and KO blood 
following induction of pancreatitis. Results are 
average ± SEM (n≥5). 
Figure S6. qPCR of pro-fibrotic cytokines in 
control (Cntl) and TGF-β RII KO (KO) pancreata 
at the indicated time following induction of 
pancreatitis. Results are average ± SEM (n≥5). 
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Abstract 
The exocrine pancreas exhibits a distinctive 
capacity for tissue regeneration and renewal 
following injury. This regenerative ability has 
important implications for a variety of disorders, 
including pancreatitis and pancreatic cancer, 
diseases associated with high morbidity and 
mortality. Thus, understanding its underlying 
mechanisms may help develop therapeutic 
interventions. Serotonin has been recognized as 
a potent mitogen for a variety of cells and tissues. 
Here we investigated whether serotonin exerts a 
mitogenic effect in pancreatic acinar cells in three 
regenerative models, namely inflammatory tissue 
injury following pancreatitis, tissue loss following 
partial pancreatectomy and thyroid hormone 
stimulated acinar proliferation. Genetic and 
pharmacological techniques were used to 
modulate serotonin levels in vivo. Acinar de-
differentiation and cell cycle progression during 
the regenerative phase were investigated over 
the course of two weeks. By comparing acinar 
proliferation in the different murine models of 
regeneration, we found that serotonin did not 
affect clonal regeneration of mature acinar cells. 
However, it was required for acinar de-
differentiation following inflammation-mediated 
tissue injury. Specifically, lack of serotonin 
resulted in delayed up-regulation of progenitor 
genes, delayed formation of acinar-to-ductal 
metaplasia and defective acinar cell proliferation. 
We identified serotonin-dependent acinar 
secretion as a key step in the progenitor-based 
regeneration, as it promoted acinar cell de-
differentiation and the recruitment of type 2 
macrophages. Finally, we identified a regulatory 
Hes1-Ptfa axis in the uninjured adult pancreas 
activated by zymogen secretion. Our findings 
indicate that serotonin plays a critical role in the 
regeneration of the adult pancreas following 
pancreatitis by promoting de-differentiation of 
acinar cells.  
Keywords: serotonin; acinar secretion; de-
differentiation; regeneration; ADM; pancreatitis; 
partial pancreatectomy. 
Introduction 
Despite a low homeostatic turnover, the adult 
exocrine pancreas has the ability to regenerate 
following an inflammatory insult. An increasing 
number of reports have revealed that during this 
regenerative process acinar cells, which 
constitute the most abundant cell population of 
the exocrine tissue,  transiently de-differentiate 
and initiate a genetic program resembling the one 
found in embryonic pancreatic precursors 
(recently reviewed in [1,2]). Although numerous 
studies have identified crucial factors involved in 
the regeneration of acinar cells, the precise 
mechanisms initiating the cascade of events 
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leading to their de-differentiation have not yet 
been identified. Serotonin (5-hydroxytryptamine, 
5-HT), a monoamine stored and released by 
circulating platelets, has long been recognized as 
a potent bioactive molecule with mitogenic effects 
not only during embryonic development [3,4] but 
also in adult cells [5]. Examples of the mitogenic 
role of 5-HT in adult tissues include liver 
regeneration following hepatectomy [6],   
megakaryocyte colony formation [7], pulmonary 
artery smooth muscle cell proliferation [8] and 
beta cell expansion during pregnancy [9].  
We recently showed that 5-HT plays a major role 
in the pathophysiology of the exocrine pancreas 
where it promotes acinar cell secretion and 
exacerbates the severity of inflammation at the 
onset of acute pancreatitis [10]. Here we 
investigated whether 5-HT acts as a mitogen for 
pancreatic acinar cells and thus promotes tissue 
regeneration. To this aim, we compared three 
types of regenerative stimuli, namely cerulein-
induced pancreatitis, partial pancreatectomy and 
thyroid hormone supplementation, in mice 
deficient in peripheral 5-HT (tryptophan 
hydroxylase 1 knocked-out, TPH1-/-), and in wild 
type mice supplemented with 5-HT precursor. 
Material and methods 
Animal experiments 
All animal experiments were performed in 
accordance with Swiss federal animal regulations 
and approved by the cantonal veterinary office of 
Zurich. Pancreatitis was induced in adult (8-10 
weeks of age) wild-type (WT) C57BL/6 (Harlan 
Laboratories, Horst, The Nederlands) and TPH1-/- 
mice [11] on a C57BL/6 background (own 
breeding) via six intra peritoneal (i.p.) injections 
of 50 µg/kg cerulein administered hourly over a 
two week period, as described in Supplementary 
Materials and Methods and [12]. Pancreatectomy 
was performed according to [13], with the 
procedure adapted to remove 60% of the organ. 
400 µg/kg 3,5,3-L-tri-iodothyronine (T3) was 
administered daily via i.p. injections for six days.  
20 mg/kg 5-hydroxytryptophan (5-HTP) was 
administered by two subcutaneous injections per 
day, 12 hours apart. The treatment was started 
one day before cerulein treatment; control 
animals received 0.9% NaCl injections.  
Histology, immunohistochemistry and 
immunoblotting 
Detailed protocols and primary antibodies used in 
this study are listed in Supplementary Materials 
and Methods. Quantification of labelled cells was 
performed in at least 10 randomly selected high-
power fields (×100) per slide. Non-acinar tissue 
areas (islets, vessels, fibrotic tissue) were 
excluded from the analysis. 
Electron microscopy analysis 
WT and TPH1-/- mice were harvested 8 hours 
after the beginning of cerulein treatment. Sliced 
pancreata were fixed in 2% glutaraldehyde/1% 
paraformaldehyde in 0.1M Na/K-phosphate for 90 
min. After washing, the samples were postfixed 
with 1% osmium tetroxide in 0.1M Na/K-
phosphate for one hour, dehydrated in a graded 
ethanol series, transferred to acetone for 
embedding in Epon and polymerized at 60°C for 
2.5 days. Ultrathin sections were stained with 
uranyl acetate and lead citrate and examined at 
an acceleration voltage of 100 kV in a Philips CM 
12 transmission electron microscope (Eindhoven, 
The Netherlands) equipped with a CCD camera 
(Ultrascan 1000, Gatan, Pleasanton, CA).  
Transcript analysis 
Total RNA was extracted from pancreata as 
previously described [14] and reverse transcribed 
with qScript™ cDNA SuperMix (Quanta 
Biosciences). Transcript levels were normalized 
using 18S rRNA as a reference and expressed 
as fold regulation relative to the value of 
untreated control animals. Taqman probes 
(Applied Biosystems) used in this study are listed 
in Supplementary Materials and Methods. 
Results 
Lack of 5-HT results in defective acinar cell 
proliferation and delayed ADM formation  
To test whether 5-HT is mitogenic for acinar cells, 
we compared acinar proliferation following 
induction of pancreatitis in WT and  in TPH1-/- 
mice, characterized by reduced 5-HT levels in the 
periphery but normal 5-HT signaling in the 
nervous system [10]. Unexpectedly, TPH1-/- 
animals showed a significantly higher number of 
acinar cells positive for the general cell cycle 
activation marker Ki67 after one week of cerulein 
treatment compared with WT animals, while the 
number of bromodeoxyuridine (BrdU) positive 
cells in G1/S phase was similar in the two strains. 
Phospho-histone H3 (pH3) positive acinar cells in 
G2/M phase increased in TPH1-/- mice only 14 
days after the beginning of the treatment (Fig. 
1A, S1A). Acinar and interstitial cells were 
distinguished based on nuclear size, shape and 
location, as shown in Fig. S1B, C. Quantification 
of of acinar cells in G2 phase, displaying 
punctuate pH3 staining, and in mitotic phase, 
with homogeneous nuclear pH3 staining [15], 
showed a reduced transition into mitotic phase in 
TPH1-/- animals one week after induction of 
pancreatitis (Fig. 1B).  
In addition, formation of acinar-to-ductal 
metaplasia (ADM), a transient trans-
differentiation observed during pancreatitis-
induced regeneration, was delayed in TPH1-/- 
mice three days after induction of pancreatitis 
(Fig. 1C). The slower kinetics of ADM formation 
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was not the result of defective expression or re-
localization of β-catenin, a key a transcriptional 
activator promoting ADM formation [16]. β-
catenin was similarly localized on the plasma 
membrane and nuclei of intact acinar cells in both 
strains (Fig. 1D) and was also found in ADM of 
WT animals and in the rare areas with reduced 
amylase content in TPH1-/- mice (Fig. 1E, 
arrowheads). Seven days after pancreatitis, 
mature clustered ductal structures were visible in 
TPH1-/- mice and were similar to WT ADMs in 
terms of β-catenin expression, Sox9 up-
regulation, amylase down-regulation and 
activation of αSma-positive stellate cells (Fig. 2A, 
S2). Taken together, these data indicate that, 
upon cerulein stimulation, TPH1-/- acinar cells are 
able to initiate the cell cycle; however, they 
display defective cell cycle progression and 
delayed ADM formation.  
Lack of 5-HT delays acinar de-differentiation 
during pancreatitis 
Proliferation of pancreatic acinar cells is 
preceded by a temporary de-differentiation and 
up-regulation of markers normally associated 
with pancreatic ductal or progenitor cells [17]. 
Concomitant with reduced ADM formation, TPH1-
/- mice showed delayed up-regulation of the 
ductal marker cytokeratin 19 (CK19) three days 
after induction of  pancreatitis (Fig. 2A, B). In 
addition, delayed up-regulation was also 
observed for several progenitor markers, 
including Sox9, Hes1, Notch1, Hnf1β. In addition, 
ductal and progenitor gene expression was 
higher in TPH1-/- than in WT animals after 14 
days of pancreatitis, with the exception of Aldh1, 
the expression of which was comparable in the 
two strains (Fig. 2A, B). 
Noteworthy, delayed progenitor gene up-
regulation in TPH1-/- mice was not accompanied 
by defective down-regulation of genes typical of 
the differentiated state, such as secretory granule 
enzymes and transcription factors controlling 
acinar cell identity, such as Mist-1[18-20] (Fig. 
S3). These data indicate that WT and TPH1-/- 
mice responded equally to the cerulein stimulus 
by down-regulating genes specific to mature 
differentiated acinar cells. However, amylase 
content did not decrease in TPH1-/- acini, as 
quantified by western blotting (Fig. 3A), 
enzymatic activity (Fig. 3B) and 
immunofluorescence analysis (Fig. 3C), 
indicating that down-regulation of zymogen 
transcripts was not sufficient to induce zymogen 
loss in these mice. Autophagy can reduce 
zymogen content by intracellular degradation 
[21]. However, autophagy was not differentially 
regulated in TPH1-/- mice, as shown by 
comparable processing of the autophagic protein 
LC3 (Fig. S4A). Similarly, autophagic marker p62 
[22] showed widespread expression in acini at 8 
hours and down-regulation one day after 
induction of pancreatitis in both strains (Fig. S4B, 
C).  
Increased zymogen secretion promotes 
acinar de-differentiation during acute 
pancreatitis 
An alternative cellular mechanism explaining 
zymogen loss observed in acinar cells following 
pancreatitis could be the secretion of zymogens 
into extracellular space. We previously showed 
that TPH1-/- mice have impaired zymogen 
secretion [10]. This defective secretory process 
was further investigated at the ultrastructural 
level. Electron microscopy analysis revealed that 
zymogen granules were more tightly packed in 
TPH1-/- than in WT mice, both in control and after 
cerulein treatment (Fig. 3D). Furthermore, size 
distribution analysis showed that granule size, 
comparable in the two strains in the untreated 
controls, increased after stimulation of secretion, 
indicative of granule swelling preceding content 
expulsion [23]; however, the enlargement was 
higher in TPH1-/- (Fig. 3E), presumably a 
consequence of impaired secretion. Thus, our 
results show that reduced zymogen secretion 
observed in the absence of 5-HT is associated 
with defective zymogen loss followed by delayed 
up-regulation of progenitor genes. To test 
whether 5-HT-dependent zymogen secretion is 
required to initiate acinar de-differentiation 
following pancreatitis, we increased zymogen 
secretion 24 hours before cerulein administration 
by treatment with 5-hydroxytryptophan (5-HTP) 
(regimen scheme depicted in Fig. 4A), a 
precursor of serotonin that dose-dependently 
stimulates apical secretion of zymogens into 
pancreatic ducts (reviewed in [24]). This 
stimulated secretion is associated with a 
protective effect during induction of acute 
pancreatitis [25-27]. Under 5-HTP 
supplementation and one day of pancreatitis, we 
also observed lower levels of inflammatory 
infiltrates in the pancreas (Fig. 4B), chemokine 
expression (Fig. 4C) and serum amylase (Fig. 
4D), likely due to the increased 5-HTP-stimulated 
apical secretion counteracting the aberrant baso-
lateral secretion induced by cerulein. The 
reduced severity of the disease did not translate 
in reduced acinar cell de-differentiation, as 5-
HTP+cerulein-treated mice showed robust 
amylase loss in the pancreas similar to cerulein-
treated mice (Fig. 4E). In addition, these mice 
had increased RNA levels of progenitor gene 
Hes-1 (Fig. 4F) and earlier expression of Sox-9 in 
acinar cell nuclei (Fig. 4G). These results suggest 
that stimulation of zymogen secretion enhances 
acinar de-differentiation following induction of 
pancreatitis. However, despite reducing the initial 
inflammation, 5-HTP supplementation (regimen 
scheme depicted in Fig. S5A) was not sufficient 
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to promote pancreatic regeneration, as shown by 
comparable levels of acinar and interstitial cell 
replication (Fig. S5B) and inflammatory cell 
infiltration (Fig. S5C) three days after pancreatitis 
induction. In addition, increasing the dosa of 5-
HTP supplementation stimulated the expression 
of progenitor (Fig. S5D) and inflammatory genes 
(Fig. S5E) compared to one set of 5-HTP. Six 
doses of 5-HTP supplementation further boosted 
the up-regulation of inflammatory genes (Fig. 
S5F), and resulted in an increased trend of acinar 
cell replication (Fig. S5G), ADM formation (Fig. 
S5H) and inflammatory infiltration (Fig. S5I), 
suggesting that supplementation with exogenous 
5-HTP did not ameliorate disease progression. 
Lack of 5-HT delays the expression of MMPs 
during pancreatitis 
As inflammatory cells play an active role in ADM 
formation, we then tested the level of pancreatic 
inflammation in the two strains. TPH1-/- mice 
showed reduced inflammation after one [10] and 
three days of pancreatitis (Fig. 4H, S6A). At this 
time point, expression of type-2 macrophage 
markers Mgl1 and Mrc1 was also reduced in 
TPH1-/- mice, while the type-1 marker Nos2 was 
comparable in the two strains (Fig. 4I), 
Macrophage marker expression increased in 
TPH1-/- mice at later time points (Fig. S6B). 
Cytokines secreted by macrophages stimulate 
matrix metalloproteinase (MMP) synthesis and 
secretion in acinar cells, thus driving digestion of 
extracellular matrix and ADM formation [28]. 
Concomitant with reduced macrophage 
infiltration, TPH1-/- mice showed a reduced trend 
of MMP7 (Fig. 4L) and TNFα expression (Fig. 
S6C). Analysis of vascular associated factors, 
including CD146 and VEGF, did not show 
alterations in the two strains after three days of 
pancreatitis, when the major ADM difference was 
observed, but their expression remained elevated 
in TPH1-/- mice after 14 days of the disease (Fig. 
S6D). 
To test whether a reduced extracellular matrix 
digestion contributed to delayed ADM formation, 
we isolated pancreatic acini with collagenase and 
compared their de-differentiation after culture in 
suspension for 24 hours, as described [29]. In 
this in vitro setting, de-differentiation was 
comparable in WT and TPH1-/- acini, with or 
without exogenous 5-HT added to the medium 
(Fig. 4M), suggesting that the 5-HT mediated 
effect is exerted up-stream of extracellular matrix 
digestion. 
Lack of 5-HT does not alter clonal 
regeneration of acinar cells following partial 
pancreatectomy and T3 administration. 
As we found that 5-HT supports progenitor-based 
regeneration following pancreatitis, we then 
investigated whether zymogen secretion is also 
required for pancreatic regeneration that does not 
depend on robust acinar de-differentiation and 
activation of progenitor genes. To this aim, we 
analyzed acinar replication following 60% partial 
pancreatectomy (PPX) that triggers a 
regenerative response preferentially based on 
clonal division of differentiated acinar cells.  
Acinar replication, albeit lower than the one 
induced after pancreatitis at all the time points 
analyzed, peaked one week following PPX (Fig. 
5A). Importantly, TPH1-/- mice did not show 
accumulation of Ki67 positive acinar cells (Fig. 
5A, B). The replication peak was not preceded by 
robust expression of progenitor genes, the up-
regulation of which was lower than during 
pancreatitis and comparable in the two strains, 
with the exception of Hes1 that increased at the 
two week time point only in WT mice (Fig. 5C). In 
addition, pancreata isolated after pancreatic 
resection showed comparable amylase content 
(Fig. 5D) and minimal levels of inflammation, 
apoptosis and fibrosis in the two strains (Fig.S7A-
C). To test the effect of 5-HT in another model of 
inflammation-independent regeneration, we 
induced acinar proliferation by administering the 
thyroid hormone 3,5,3-L-tri-iodothyronine (T3) 
[30,31]. T3 treated WT and TPH1-/- mice showed 
similar levels of acinar replication (Fig. 5E) and 
minimal leukocyte infiltration (Fig. 5F). 
Collectively, these data revealed that acinar 
replication following PPX and T3 administration is 
not affected by the lack of 5-HT.  
5-HT receptors are up-regulated during 
pancreatic regeneration 
As 5-HT signals via specific 5-HT receptors and 
transporter, we then compared their expression 
during pancreatic regeneration. Type 1 and 2 
receptors, known to play a role in regeneration of 
liver and heart [6,32,33] and found up-regulated 
in pancreatic cancer [34], were up-regulated 
following pancreatitis in WT mice and showed a 
delayed kinetic in TPH1-/- animals (Fig. S8A). 
Analysis of samples with reduced inflammation, 
such as TPH1-/- and 5-HTP supplemented WT 
mice one day after pancreatitis, indicated that 
inflammatory cells substantially contribute to the 
observed level of receptor expression, except in 
the case of 5-HT2A (Fig. S8B). Similarly, PPX 
samples, characterized by minimal tissue 
inflammation, showed lower 5-HT receptor and 
transporter expression compared with 
pancreatitis specimens (Fig. S8C). Interestingly, 
expression of 5-HT2B robustly increased in WT 
mice 14 days after PPX, when up-regulation of 
progenitor Hes1 was observed. 
To test whether acinar cells also express 5-HT 
receptors and transporter, we isolated pancreatic 
acini one day after pancreatitis induction. 
Expression of 5-HT receptors but not transporter 
increased in acinar cells following the disease 
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and TPH1-/- acini had an opposite trend of 
receptor expression compared with WT cells, 
showing lower type 1 and higher type 2 receptor 
levels (Fig. S8D). Collectively, these results 
indicate that pancreatic regeneration is 
associated with up-regulation of 5-HT receptors 
and transporter, which can be expressed not only 
by infiltrating cells but also by pancreatic acini. 
Hes1-Ptf1a axis is activated in the uninjured 
adult pancreas 
As we observed that 5-HTP treatment enhanced 
acinar de-differentiation following induction of 
pancreatitis (Fig. 4E, F), we then tested whether 
this regulation was observed also in the absence 
of tissue damage.  5-HTP-treated WT mice had 
normal levels of serum and tissue amylase (Fig. 
4C, D) and no Sox9 expression in acinar cells 
(Fig. 6A), suggesting that increased secretion 
into ducts is not sufficient to activate acinar de-
differentiation. However, 5-HTP treatment 
increased the expression of the progenitor gene 
Hes1 in the pancreas (Fig. 6B), albeit at a lower 
level than following 5-HTP+cerulein treatment. 
Hes1 is a critical orchestrator of pancreatic 
embryogenesis (reviewed in [35]),  as it  
regulates maintenance of progenitor cells and 
timing of cell differentiation by antagonizing the 
function of Ptf1a, a basic helix-loop-helix 
transcription factor that promotes zymogen 
synthesis [36]. Hes1 up-regulation following 5-
HTP treatment was concomitant with Ptf1a down-
regulation (Fig. 6B). Moreover, early time points 
following cerulein treatment showed initial Ptf1a 
up-regulation followed by Hes1 expression and 
subsequent Pft1a down-regulation, the level of 
which was reduced in TPH1-/- mice with delayed 
Hes1 up-regulation (Fig. 6C). This suggests that 
the inhibitory function of Hes1 on Ptf1a 
expression described during development may 
be active also in the adult pancreas. We further 
explored the Hes1-Ptf1a regulation in an in vitro 
system where the acinar cell line AR42J was 
stimulated toward a more differentiated and 
secretory phenotype by treatment with 
dexamethasone [37]. 48 hours of 
dexamethasone treatment changed the cell 
morphology from a more spheroid to flattened 
shape (Fig. S9A), led to decreased replication of 
AR42J cells (Fig. S9B), increased amylase 
content (Fig. 6D) and decreased Sox-9 
expression (Fig. 6E). Similar to what we 
observed in vivo, AR42J differentiation showed 
an initial increase of Ptf1a expression that was 
then reduced following Hes1 up-regulation (Fig. 
6F). 
Taken together, the in vivo and in vitro results 
presented here show that conditions of increased 
zymogen secretion and synthesis in acinar cells 
are associated with the activation of the Hes1-
Ptf1a axis. These data not only indicate that 
different progenitor genes are regulated in a 
different manner in acinar cells, but also that the 
Hes1-Ptf1a axis may contribute to maintain 
physiological zymogen levels in the adult 
pancreas in the absence of acinar cell damage. 
Discussion 
The remarkable regenerative capacity observed 
in organs of several non-mammalian vertebrates 
often involves the de-differentiation of mature 
cells (reviewed in [38]). Notably, cell de-
differentiation is also observed in the 
regeneration of the adult exocrine pancreas of 
mammals following pancreatitis. In this organ, 
differentiated acinar cells transiently revert into a 
progenitor state following injury, thus likely acting 
as facultative progenitor cells and initiating a 
replicative program leading to exocrine tissue 
repair (reviewed in [1,39,40]). This de-
differentiation of adult pancreatic acinar cells is a 
critical process within the regenerative 
mechanism, as bona fide resident stem cells 
have not been reported in the adult pancreas 
(reviewed in [39]). Our results showed that, 
differently from what has been observed in other 
cell types and tissues [6,33,41-46], 5-HT does 
not act as a strong mitogen for acinar cells, as 
acinar replication was unchanged in vivo in the 
absence of 5-HT following 60% pancreatectomy 
and T3 stimulation and in vitro in AR42J acinar 
cells treated with 5-HT (data not shown). 
However, 5-HT is required for acinar de-
differentiation following inflammatory-mediated 
tissue damage. In this context, it is important to 
mention that 60% pancreatectomy is 
characterized by a moderate level of acinar cell 
de-differentiation and replication compared with 
the more robust regeneration observed during 
induction of pancreatitis. These observations 
support the notion that, according to the type and 
extent of tissue injury, the mammalian pancreas 
has the ability to trigger different regenerative 
mechanisms, which are driven by activation of a 
progenitor-like program or by a simple, clonal 
proliferation of differentiated acinar cells 
(reviewed in [39,47]). Furthermore, as progenitor-
based and clonal modalities of regeneration are 
not mutually exclusive and are likely to co-exist, 
the clonal regeneration independent from 
zymogen secretion is likely to account for the 
replication observed in TPH1-/- mice with 
compromised progenitor-based regeneration. 
A major challenge undertaken in our study was to 
elucidate the mechanisms by which 5-HT affects 
acinar de-differentiation and ADM formation. We 
identified 5-HT-dependent secretion of zymogen 
content as one of the step promoting up-
regulation of progenitor-like genes, suggesting 
that physical removal of zymogens via secretion 
has to occur to allow de-differentiation of adult 
acinar cells. However, additional mechanisms are 
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likely to contribute to the observed delayed de-
differentiation and ADM formation in the absence 
of 5-HT. We found that reduced secretion in 
TPH1-/- mice limits chemokine production and 
leukocyte infiltration in the early stages of 
cerulein-induced pancreatitis ([10] and this work). 
Thus, it is possible that the few infiltrating 
leukocytes released a limited amount of pro-
inflammatory cytokines that may not have been 
sufficient to stimulate acinar de-differentiation 
and ADM formation. Indeed, TPH1-/- mice had 
reduced levels of TNFα and MMP, both factors 
critical to induce ADM formation [28]. The 
comparable de-differentiation observed in vivo in 
isolated acini supports the hypothesis that the 5-
HT effect is not acinar cell autonomous but is 
mediated by macrophage-stimulated extracellular 
matrix digestion. However, it has to be noted that, 
despite sharing phenotypic similarities, the in 
vitro acinar de-differentiation may not completely 
reflect the molecular mechanisms occurring in 
the in vivo de-differentiation upon pancreatitis 
induction. Indeed, the process of acinar isolation 
per se activates Ras and its down-stream 
effectors ERK and AKT [29], the activity of which 
promotes cell de-differentiation. Thus, it is 
possible that the in vitro procedure bypasses a 
cell autonomous, 5-HT-mediated process 
occurring in vivo. In support of this hypothesis, 5-
HT has been reported to act upstream Ras-
dependent ERK1/2 activation via binding to 
different 5-HT receptors [48-50]. 
In this regard, an alternative explanation for the 
aberrant progenitor-based regeneration observed 
in TPH1-/- mice is that 5-HT directly stimulates the 
expression of progenitor genes via 5-HT receptor 
signaling or intracellular mechanisms following its 
uptake. Of note, type-1 5-HT receptors were 
recently described to promote proliferation of 
human pancreatic cancer cells [34]. Type 1 and 2 
5-HT receptors were up-regulated during 
pancreatic regeneration and we also observed a 
robust up-regulation of type-2 5-HT receptors 
concomitant with the progenitor gene Hes1 
expression following PPX. Finally, we also 
discovered an activation of the Hes1-Ptf1a axis in 
the uninjured pancreas.  Both under in vivo and 
in vitro experimental conditions, Hes1 up-
regulation was accompanied by down-regulation 
of Ptf1a expression. This suggests the presence 
of a tightly regulated control of Ptf1 expression by 
Hes1 in the adult pancreas, reminiscent of the 
embryonic situation. Hence, our data are in 
support of a dual role of Hes1 in the 
pathophysiology of the pancreas. In physiological 
situations, increased zymogen secretion is 
associated with moderate Hes1 up-regulation, 
which limits Ptf1a expression and thus 
contributes to acinar homeostasis by preventing 
excessive zymogen expression. In pathological 
situations that trigger acinar replication, a higher 
Hes1 up-regulation occurs with a consequent 
reduction of transcription factors and proteins 
required to maintain acinar function. This down-
regulation of differentiation genes may provide 
the cells with the suitable environment to up-
regulate a broader set of progenitor genes, 
leading to a robust acinar proliferation and organ 
repair. Collectively, these results indicate that 
expression of progenitor genes is not a 
synchronous event. Therefore, similarly to what 
was observed in the determination of diverse cell 
fates during development [56], the different time 
of expression of these transcription factors in the 
adult pancreas may reflect their distinctive 
function during homeostasis and regeneration.  
While highlighting the impact that 5-HT exerts on 
the de-differentiation and proliferation abilities of 
pancreatic cells under different regenerative 
conditions, this study includes several limitations. 
First, the use of a general TPH1 knocked out 
model system precludes the dissection of the 
individual cell contribution in the synthesis of 5-
HT. In addition, further studies are necessary to 
characterize the role of the different 5-HT 
receptors present on acinar and non-acinar cells 
to fully understand their contribution during 
pancreatic regeneration.  Finally, an aspect of the 
5-HT biology that has not been addressed in this 
study is a thorough characterization of vascular 
function. Disturbances in microcirculation, 
including vasoconstriction, are associated with 
acute pancreatitis (reviewed in [57]).  As 5-HT is 
a potent vasoconstrictor, it will be worth exploring 
whether alterations in the vascular biology 
contribute to the observed phenotype in TPH1-/- 
mice. 
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Figure legends 
Figure 1. Lack of 5-HT results in defective acinar 
cell proliferation and delayed ADM formation. A. 
Quantification of replication markers expressed in 
pancreatic acinar cells showed increased number 
of Ki67 positive cells in TPH1-/- mice after 7 and 
14 days of pancreatitis.  B. Relative amount of 
acinar cells in G2 and M phases determined by 
pH3 staining pattern 7 and 14 days after 
pancreatitis induction. Data are expressed as 
percentage of cells with punctated (G2 phase) or 
complete nuclear staining (M phase) out of the 
total number of pH3 positive cells. C. 
Hematoxylin-Eosin (H&E)-staining and ADM 
quantification showed lower amount of ADM 
(asterisks) in TPH1-/- mice after three days of 
pancreatitis induction. Lower panels, enlarged 
views of insets three days after pancreatitis. Note 
the presence of mature ADM in WT mice 
characterized by loss of acinar content and 
tubular complex formation. TPH1-/- pancreata 
presented sporadic de-regulation of acinar 
content (stars) without re-organization into 
tubular structures. D. Confocal pictures showing 
nuclear localization of β-catenin in WT and TPH1-
/- pancreata three days after induction of 
pancreatitis. Nuclei are stained with DAPI (blue). 
E. Amylase and β-catenin staining three days 
after induction of pancreatitis. Circled area and 
asterisk in WT pancreata represent ADM. Right 
panels, enlarged views of insets. Arrowhead, 
area with reduced amylase content and 
increased β-catenin expression in TPH1-/- 
pancreata. Results are average ± SEM (n=5), 
*p<0.05. Scale bars: 50 µm. 
Figure 2. Lack of 5-HT delays acinar de-
differentiation during pancreatitis. A. Cytokeratin 
19 (CK19), Sox9, β-catenin and amylase staining 
three and seven days after induction of 
pancreatitis. Nuclei in the IF pictures are stained 
with DAPI (blue).  B. qPCR of ductal and 
progenitor markers during the indicated times of 
cerulein-induced pancreatitis showed delayed 
expression in TPH1-/- pancreata. Results are 
average ± SEM (n=5), *p<0.05. Scale bars: 50 
µm. 
Figure 3. Lack of 5-HT prevents loss of amylase 
during pancreatitis. Biochemical determination of 
amylase activity (A) and immunoblotting of 10 µg 
of proteins (B) showed down-regulation of 
amylase in pancreatic tissue of WT but not TPH1-
/- mice one day after cerulein treatment. C. 
Immunostaining of amylase during 14 days of 
pancreatitis induction showed decreased protein 
expression in WT but not in TPH1-/- mice one day 
after cerulein treatment. D. Electron micrographs 
of WT and TPH1-/- pancreata. Note the close 
proximity of zymogen granules with reduced 
inter-granule space in TPH1-/- mice, both in 
control and cerulein treatment. L, acinar lumen 
with evident microvilli. V, zymogen vesicle, M, 
mitochondrion. RER, rough endoplasmic 
reticulum. Right panel, quantification of the area 
occupied by granules expressed as percentage 
of total area. E. Size distribution of zymogen 
vesicle diameter. Note the higher abundance of 
vesicles with large diameter in TPH1-/- mice 
following pancreatitis induction. Results are 
average ± SEM (n=5), *p<0.05. Scale bars: 1 µm. 
Figure 4. A. Scheme depicting the combined 
regimen with 5-HTP and cerulein (Cer). 0.9% 
NaCl was used as vehicle control. Circles 
indicate days of treatment starting from the first 
cerulein injection and triangles indicate days of 
animal harvest. Pan-leukocyte immunostaining 
with anti-coronin 1 (B) and qPCR of pro-
inflammatory chemokine MCP-1 (C) showed 
lower inflammation upon 5-HTP supplementation 
one day after induction of pancreatitis. Serum (D) 
and tissue (E) levels of amylase 8 hours after 
pancreatitis induction following 5-HTP 
supplementation. qPCR of Hes1 (F) and 
immunostaining of Sox9 (G) one day after 
pancreatitis induction following 5-HTP 
supplementation. H. inflammarory cell 
quantification after PU.1 immunostaining showed 
reduced infiltration in TPH1-/- mice three days 
after pancreatitis induction. I. qPCR of type1 and 
2 macrophage markers three days after 
pancreatitis induction. L. qPCR of matrix 
metalloproteinase 7 (MMP7) at the indicated 
days of pancreatitis induction. M. qPCR of 
progenitor and zymogen markers in isolated acini 
(inset) cultured for 24 hours in suspension to 
induce differentiation. 5-HT was added to the 
medium at 20 µM concentration. Results are 
average ± SEM (n=5), *p<0.05. Scale bars: 50 
µm. 
Figure 5. Lack of 5-HT does not alter clonal 
regeneration of acinar cells following 60% 
pancreatectomy (PPX) and thyroid hormone T3 
stimulation. A. Quantification of replication 
markers expressed in pancreatic acinar cells at 
the indicated times after partial pancreatectomy. 
B. Immunostaining of Ki67 at the indicated time 
points following PPX. Pictures represent an inset 
(1:10) of the original images used for Ki67 
quantification. C. qPCR of progenitor-cell 
markers at the indicated times after PPX.  Note 
that WT but not TPH1-/- mice up-regulated Hes1 
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expression 14 days after surgery. Expression 
levels obtained in WT mice after cerulein induced 
pancreatitis (WT CIP) are shown as a 
comparison. D. Immunostaining of amylase 
showed comparable protein expression in WT 
and TPH1-/- mice following PPX. E. Quantification 
of Ki67 expressed in pancreatic acinar cells 
following T3 administration for six days. F. Pan-
leukocyte immunostaining with anti-coronin1 
showed comparable level of inflammatory cells  
in control and treated mice. Results are average 
± SEM (n=3-5), *p<0.05. Scale bars: 50 µm. 
Figure 6. Increased zymogen secretion 
stimulates Hes1 expression in the uninjured 
pancreas. A. Left panel, immunostaining of Sox9 
following 5-HTP supplementation showed nuclear 
expression of the protein in interstitial and centro-
acinar cells but not in acinar cells. Right panel, 
qPCR analysis showed comparable levels of 
Sox9 transcripts in control and 5-HTP-treated 
pancreata. B. qPCR analysis showed Hes-1 up-
regulation and Ptf1a down-regulation in mouse 
pancreata following 5-HTP treatment. C. qPCR of 
Ptf1a and Hes1 expression in WT and TPH1-/- 
mice in the early phases after pancreatitis 
induction. Dexamethasone treatment of 
pancreatic acinar AR42J cells for 48 hours 
increased cellular content of amylase (D) and 
reduced Sox9 expression at both transcript (left 
panel) and protein (right panel) levels (E), 
indicative of increased cellular differentiation. F. 
qPCR analysis showed a time-dependent 
increase of Hes1 and decrease of Ptf1a 
expression in dexamethasone-treated cells. 
Results are average ± SEM (n=5), *p<0.05. Scale 
bars: 50 µm. 
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Supplementary Online Materials  
Materials and Methods 
Biochemical reagents 
Unless otherwise stated, all chemicals were 
purchased from Sigma and cell culture reagents 
from Gibco-BRL. Stock solution for 5-HTP and 
cerulein were made in NaCl, dexamethasone in 
F-12K medium. 
Pancreatitis induction 
Animals received six hourly injections of 50 µg/kg 
cerulein on Monday, Wednesday and Friday and 
were harvested on Tuesday after one set of 
injections (day 1), on Thursday after two sets of 
injections (day 3) or on Monday after three (day 
7) or six (day 14) sets of injections, without 
receiving cerulein treatment on the same day. 
 Pancreatic cell culture 
Pancreatic acini were isolated from WT and 
TPH1-/- mice was performed as previously 
described in [1]. Cells de-differentiaion was 
induced according to [2] by culturing isolated 
acini in suspension for 24 hours in RPMI 1640 
glutamax medium supplemented with 10% fetal 
bovine serum, 50 U/mL penicillin, 50 µg/mL 
streptomycin, 0.1 mg/ml soybean trypsin inhibitor. 
****** 
AR42J cells were maintained in Kaighn’s 
modified Ham’s F-12 medium with 20% fetal 
bovine serum (FBS), 50 U/mL penicillin, and 50 
µg/mL streptomycin at 37°C in a 5% CO2 
atmosphere. Differentiation was induced by 
incubating adherent cells with 50 nM 
dexamethasone.  
Biochemical analysis of amylase activity 
For determination of amylase levels present in 
the serum, blood was sampled by heart puncture. 
For determination of amylase levels present in 
pancreatic tissue, pancreata were homogenized 
with RIPA buffer containing protease inhibitor 
cocktail (complete ultra-tablets mini, Roche 
Diagnostics, Mannheim, Germany). Amylase 
activity was measured using the Fuji Dri-Chem 
4000i analyzer (Glattbrugg, Switzerland).  
Immunohistochemistry 
Pancreas specimens were embedded in paraffin 
for histological analyses as described [3]. For 
immunofluorescence analysis of cultured cell 
lines, AR42J cells were fixed in 3.6% 
formaldehyde and permeabilized with 0.2% Triton 
X-100 in PBS.  Primary antibodies used in this 
study were: rabbit anti-phospho-histone 3 
(Millipore, Massachusetts, USA), rabbit anti-sox9 
(Millipore, Massachusetts, USA), rabbit anti-
cyclin E (Abcam, Cambridge, UK), rabbit anti-
coronin 1 (gift from Jean Pieters), rabbit anti-
amylase (Sigma-Aldrich, Buchs, Switzerland), 
rabbit anti Ki67 (Abcam, Cambridge, UK), rabbit 
anti-p62/SQSTM1 (MBL, Massachusetts, USA), 
rabbit anti-β-catenin (Cell Signaling, Danvers, 
USA) , rabbit anti-Pu1 (Cell Signaling, Danvers, 
USA), mouse anti-αSMA (Dako, Glostrup, 
Denmark), goat anti-amylase (Santa Cruz 
Biotechnology, California).. Secondary antibodies 
used in this study were: Biotinylated Goat Anti-
Rabbit IgG (H+L). This antibody is included in the 
VECTASTAIN® ABC kits, AlexaFluor 594, Goat 
Anti-Rabbit IgG (Life Technologies, Carlsbad, 
California, USA), FITC anti goat (***), FITC anti 
mouse (***). Nuclei were visualized with 4′, 6-
diamidino-2-phenylindole (DAPI).  Detection of 
proliferating cells in s-phase was performed with 
Invitrogen BrdU Staining Kit (Life Technologies, 
Carlsbad, California, USA). Detection of DNA 
fragmentation in apoptotic cells was performed 
with a TUNEL assay using an ApopTag 
peroxidase Kit (MP Biomedicals, Illkirch, France). 
Microscopy analyses were performed on a Nikon 
Eclipse Ti fluorescence microscope (Amsterdam, 
The Netherlands) or on a Leica SP2 AOBS 
confocal laser-scanning microscope (Leica 
Microsystems, Wetzlar, Germany), using the 
appropriate settings. Image stacks of optical 
sections were further processed using the 
Huygens deconvolution software package 
version 2.7 (Scientific Volume Imaging, 
Hilversum, NL).  
Western blotting 
Immunoblotting was performed by homogenizing 
tissue samples in RIPA buffer containing 
protease inhibitor cocktail (Roche Diagnostics, 
Mannheim, Germany). Protein concentrations 
were determined using a Bradford protein assay 
(BioRad, Hercules, CA, USA). Aliquots 
corresponding to 10 µg of proteins were 
separated by SDS-PAGE electrophoresis. 
Blotting and chemiluminescent detection of 
immunoreactive bands were performed using the 
V3 Western Workflow system (BioRad, Hercules, 
CA, USA), according to the manufacturer 
protocols. Primary antibodies rabbit anti-amylase 
(Sigma-Aldrich, Buchs, Switzerland), rabbit anti-
LC3B (Cell Signaling, Danvers, USA), and rabbit 
anti GAPDH (Sigma-Aldrich, Buchs, Switzerland) 
were incubated overnight at 4oC.  
Transcript analysis 
The following Taqman probes (Applied 
Biosystems) were used: Sox9 Mm00448840_m1, 
Hes1 Mm01342805_m1, Notch-1 
Mm00435249_m1, Mist1 (Bhlhb8) 
Mm00487695_m1, Cpa1 Mm01137017_m1, 
MCP1/CCL2 Mm00441242_m1, PTF1a 
Mm00479622_m1, Amy Mm00651524_m1, 
Aldh1a1 Mm00657317_m1, Hnf1b
 Mm00447459_m1, Hnf6 (ONECUT1) 
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Mm00839394_m1, Krt19 Mm00492980_m1, 
Cckbr Mm00432329_m1, CD146 (Mcam) 
Mm00522397_m1, Htr2a Mm00555764_m1, 
Htr2b Mm00434123_m1, SERT (Slc6a4) 
Mm00439391_m1, Mao A Mm00558004_m1, 
Mgl1 (Clec 10a) Mm00546124_m1, Nos2 
Mm00440502_m1, Mrc1 (MMR, Clec 13D) 
Mm00485148_m1, Mmp7 Mm00487724_m1, 
Pdx1 Mm00435565_m1, VEGFα 
Mm00437304_m1, IL-1b Mm00434228_m1, IL-6 
Mm00446190_m1, TNFα (17) Mm00443258_m1, 
Htr1a Mm00434106_s1, Htr1b Mm00439377_s1, 
Amy2 Rn00821330_g1, Ptf1a Rn00588645_m1, 
Hes1 Rn00577566_m1, Sox9 
Rn01751069_m1,TaqMan Ribosomal RNA Cont 
Reagents VIC (18S).  
Statistical analyses 
Groups of 5-6 animals were tested for each 
experiment. The data are expressed as the 
means ± SEM. The statistical significance of 
differences in the means of experimental groups 
was determined using an unpaired, two-tailed 
Student's t test unless otherwise stated. A p 
value < 0.05 was considered to be 
significant.  
Figure legends 
Figure S1. A. Immunostaining of Ki67, 5-bromo-
2'-deoxyuridine (BrdU) and phospho-histone 3 
(pH3) at the indicated time points following 
cerulein treatment. Pictures represent an inset 
(1:10) of the original images used for 
quantification of positive cell number. B. Acinar 
cells (Ac) positive for Ki67 were identified by 
large and round nuclei located inside the acinar 
periphery, while interstitial cells (Int) had smaller 
and elongated nuclei present outside the 
pancreatic acini. PU.1 staining confirmed that 
part of interstitial cells with elongated nuclei was 
of inflammatory origin. Limited Ki67-αsmooth 
muscle actin (αSma) co-staining showed that 
interstitial activated stellate cells were not highly 
replicative both in WT and TPH1-/- mice. Scale 
bars: 50 µm. 
Figure S2. β-catenin, Sox9 and αsmooth muscle 
actin (αSma) immunostaining seven days after 
induction of pancreatitis. Nuclei are stained with 
DAPI (blue).  Scale bars: 50 µm. 
Figure S3. qPCR of genes typical of the 
differentiated state showed similar expression in 
the two strains eight hours after cerulein 
treatment. Cpa1, carboxypeptidase 1. Results 
are average ± SEM (n=5). 
Figure S4. A. Immunoblotting and quantification 
of processed LC3 (LC3-II) one day after cerulein 
treatment. Data are expressed as percentage of 
total LC3 (I+II). Results are average ± SEM 
(n=4). B. Immunostaining of the autophagic 
marker p62 at the indicated time points following 
cerulein treatment. C. Quantification of p62 
positive areas one day after cerulein treatment. 
Data are expressed as percentage of the 
pancreatic area in the field. Scale bars: 50 µm. 
Figure S5. A. Scheme depicting the treatment 
regimen with 5-HTP and cerulein (Cer). 0.9% 
NaCl was used as vehicle control. B.  
Quantification of the replication markers Ki67 and 
pH3 expressed in pancreatic acinar (Ac) and 
interstitial (Int) cells after three days of 5-HTP 
supplementation and pancreatitis induction. C. 
Quantification of PU.1 expressing cells infiltrating 
the pancreas after three days of 5-HTP 
supplementation and pancreatitis induction. D. 
qPCR of acinar, ductal and progenitor markers 
after three days of 5-HTP supplementation and 
pancreatitis induction. E. qPCR of inflammation 
markers after three days of 5-HTP 
supplementation and pancreatitis induction. F. 
qPCR of inflammation and fibrosis markers after 
14 days of 5-HTP supplementation and 
pancreatitis induction. G. Quantification of the 
replication marker Ki67 expressed in pancreatic 
acinar cells after 14 days of 5-HTP 
supplementation and pancreatitis induction. H. 
Quantification of ADM lesions after 14 days of 5-
HTP supplementation and pancreatitis induction. 
I. Quantification of PU.1 expressing cells 
infiltrating the pancreas 14 days of 5-HTP 
supplementation and pancreatitis induction. 
Results are average ± SEM (n=5), *p<0.05. 
Figure S6. A. PU.1 immunostaining in WT and 
TPH1-/- pancreata three days after pancreatitis 
induction. B. qPCR of macrophage markers 
during the course of pancreatitis induction. C. 
qPCR of TNFα during the course of pancreatitis 
induction. D. qPCR of vascular related factors 
during the course of pancreatitis induction. 
Results are average ± SEM (n=5), *p<0.05. Scale 
bars: 50 µm. 
Figure S7. A. Pan-leukocyte immunostaining 
with anti-coronin-1 antibody two weeks after 
PPX. B TUNEL staining showed comparable 
number of apoptotic cells in intact acini in both 
strains at the indicated times following PPX. C. 
Sirius red staining showed comparable collagen 
deposition in the two strains two weeks after 
PPX. Scale bars: 50 µm. 
Figure S8. A. qPCR of 5-HT receptors and 
transporter in WT and TPH1-/- pancreata during 
the course of pancreatitis. B. qPCR of 5-HT 
receptors and transporter in WT, TPH1-/- and WT 
supplemented with 5-HTP mice 24 hours 
following pancreatitis induction. C. qPCR of 5-HT 
receptors and transporter in WT and TPH1-/- 
pancreata following pancreatectomy. D. qPCR of 
5-HT receptors and transporter and 5-HT 
deaminase enzyme monoaminooxidase A 
100 
 
(MaoA) in acini isolated from WT and TPH1-/- 
mice one day after pancreatitis induction. 
Figure S9. A. Bright field images of AR42J cells 
incubated for 2 days with dexamethasone. Note 
as the cells change morphology upon treatment. 
B. Quantification of AR42J cell number following 
48 hours incubation with 50 nM dexamethasone 
(Dexa). Results are average ± SEM (n=3). 
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7. Discussion 
 
Acinar-to-ductal metaplasia is a common feature of pancreatitis and it may represent the site 
of the strongest injury, as ADM is highly inflamed and fibrotic compared to the surrounding 
tissue. As already mentioned, the extent of ADM depends on injury type and duration. A long 
lasting injury can trigger an extended ADM development, leading to a total atrophy of acinar 
cells and functional impairment of the tissue. On one hand, ADM represents a pool of 
progenitor cells required for tissue regeneration and a remarkable plasticity of pancreatic 
cells on the other hand, it can cause tissue functional impairment and disease exacerbation.  
ADM is also important in the case of pancreatic cancer, as it is considered to be a pre-
malignant lesion and pathological conditions that stimulate ADM formation can also stimulate 
the susceptibility of these cells to tumorigenic transformation. Specifically, an activated 
tumorigenic pressure, together with cell dedifferentiation, can initiate a cell state that 
promotes cancer formation. Understanding ADM formation can help to identify therapeutic 
targets not only for pancreatitis but also for pancreatic cancer. Moreover, the capacity of 
acinar cell for plasticity makes them an attractive target for diabetes therapy where they 
might be reprogrammed into insulin-producing β-cells for transplantation. These examples 
underline the significance of ADM and hence it is critical to explain this phenomenon to 
improve health related issues. 
 
7.1 p21WAF1/Cip1 limits ADM formation but not acinar cell proliferation 
 
Pancreatic tissue injury results in ADM formation and also increased acinar cell proliferation, 
as an attempt to regenerate the damaged tissue. Cells always balance mitogenic and anti-
mitogenic factors and this balance allows the cells either to remain in a non-proliferative state 
or to enter the cell cycle and proliferate. An injury shifts this balance by activating the cell 
cycle in more cells and inducing a higher rate of proliferation. In normal tissue, the cell cycle 
is restrained by a set of different factors including cyclin-dependent kinase inhibitors like 
p21Waf1/Cip1 (p21). p21 maintains cells in G0 phase when conditions are not optimal for 
proliferation [34]. During pancreatitis, two events with opposite effects have been observed in 
acinar cells: p21 up-regulation and increased cell proliferation. Intriguingly, p21 was strongly 
expressed in acinar cells but not in ADM areas. Keeping in mind the inhibitory function of 
p21, it was logical to ask the following questions: 
• Does p21 restrain acinar cell proliferation during pancreatic regeneration? 
• Are low levels of p21 a prerequisite for ADM formation? 
• Is there an association between acinar cell proliferation rate and ADM formation? 
To address these questions we studied the course of cerulein-induced pancreatitis in p21 KO 
mice. In this study we demonstrated a higher incidence of ADM formation in the absence of 
p21. Moreover, we confirmed p21 involvement in ADM formation in vitro by showing an 
inverse correlation between up-regulation of p21 and reduction of ADM incidence. However, 
our analysis showed that p21 is a weak suppressor of mitotic activity in both acinar and ADM 
cells. Despite the fact that the cell replication rate did not increase in the absence of p21, our 
results showed that p21 can regulate the cell cycle by supressing the expression of cell cycle 
regulators, for instance cyclins. Taking into consideration these results, it is fair to state that 
p21 contributes to the inhibition of the cell cycle, however it lacks a full control of mitosis.  
Tight control of the cell cycle in acinar cells is an aspect that needs broader investigations. 
One possible explanation of why we did not detect an increased cell proliferation in p21 KO 
mice is a compensatory control of the cell cycle achieved by inducing the expression of other 
cell cycle inhibitors. Indeed, our results showed induction of other cyclin-dependent kinase 
inhibitors in the absence of p21. It is also reasonable to hypothesise that p21 KO acinar cells, 
with an activated but de-regulated cell cycle, might dedifferentiate and contribute to 
metaplasia formation instead of replicating. Thus p21 may act as a tumour-suppressor in the 
pancreas. 
The increased incidence of ADM formation might arise from different mechanisms. One 
possibility might be an increased acinar cell susceptibility to injury in the absence of p21, 
however, we did not observed increased cellular damage in p21 KO mice. Another possibility 
for increased ADM formation might be an altered functionality of non-acinar cells, for 
example immune or pancreatic stellate cells, which can trigger ADM by producing pro- or 
anti-inflammatory molecules. We did not investigate in detail the functionality of non-acinar 
cells, however, our analysis showed similar levels of stellate cell activation but increased 
levels of pro-inflammatory molecules in p21 KO mice. Finally, increased ADM may result 
from the increased senescence observed in the absence of p21. Cellular senesce is an 
irreversible arrest of cell growth induced when cells encounter any kind of stress [35]. In the 
course of pancreatitis, p21 might act as a molecular switch to promote quiescence of acinar 
cells and to limit activation of senescence. How can senescence contribute to ADM 
formation? Interestingly, senescent cells secrete pro-inflammatory cytokines and proteases 
that promote a microenviroment suitable for ADM development [35]. In support of this 
hypothesis, our results showed increased levels of these molecules that can contribute to 
ADM development. A key player mediating the increased senescence and ADM formation is 
likely to be β-catenin, the expression of which was stronger in p21 KO mice. This molecule 
has been shown to induce ADM and also mediate senescence and senescence-associated 
secretory phenotype in cancer [27, 36, 37]. 
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All in all, our findings are consistent with a critical role of p21 in restraining senescence and 
ADM formation in acinar cells. In addition, we showed that p21 has a limited activity in 
restraining acinar cell proliferation.  
 
7.2 TGF-β limits ADM formation and acinar cell proliferation 
 
TGF-β signalling plays an important role in tissue repair. TGF-β receptor II is the main 
receptor in TGF-β signalling pathway that links TGF-β ligand binding to downstream 
activation of intracellular Smads, eventually leading to target gene transcription [37].  
Many components of the TGF-β signalling, including three ligands (TGF-β1,2,3) and two 
receptors (TGF-β RI and RII), are activated during pancreatitis, indicating the significance of 
this pathway in the disease. Regarding TGF-β function in acinar cells, studies have already 
shown its’ anti-proliferative role in in vitro model systems and in vivo uninjured pancreatic 
tissue [38, 39]. However, the anti-proliferative role of TGF-β in pancreatitis and more 
importantly, during the disease progression has not been investigated yet. In addition, the 
role of this cytokine in acinar cell dedifferentiation has not been fully established. A higher 
incidence of ductal structure formation and increased acinar cell proliferation was 
demonstrated in a single study analysing the effects of abrogated TGF-β signalling in normal 
pancreatic tissue [38]. However, this study did not investigate any potential mechanisms 
promoting the displayed phenotype. To address the question whether TGF-β restricts acinar 
cell proliferation and ADM formation we knocked out TGF-β receptor II (TGF-β RII KO) 
specifically in pancreatic epithelial cells.  
Our study showed no TGF-β interference with the basal mitotic activity of acinar cells in the 
uninjured pancreas, suggesting that this signalling molecule is not required for homeostatic 
turnover of acinar cells. Of note, this result differs from the one obtained in a study using a 
dominant negative form of TGF-β RII, where an increased acinar cell proliferation in the 
uninjured pancreas was observed [38]. Interestingly, TGF-β also did not interfere with the 
acinar cell cycle in the early onset of pancreatitis, but elicited a suppressor role of acinar cell 
proliferation when the severity of the disease advanced. In addition, the increased number of 
acinar cells positive for the general cell cycle activation marker Ki67 but not for the mitosis 
marker pH3 observed in TGF-β RII KO mice indicates that TGF-β regulates the initial cell 
cycle phase but not the final transition to mitosis. The observed down-regulation of cyclin-
dependent kinase inhibitor p16 in the absence of TGF-β RII might be the reason for the 
increased activation of the cell cycle. However, other cell cycle inhibitors can compensate the 
down-regulation of p16 and further limit the cell cycle progression and in this way preventing 
completion of the mitosis. 
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The core result of our study showed that TGF-β is potent enough to reduce the incidence of 
ADM formation. In the absence of TGF-β RII a higher incidence of ADM formation was 
observed together with higher expression of EGF receptor, which is a well-known ADM 
inducer. Thus, a possible crosstalk between TGF-β/EGFR, where TGF-β  inhibits the 
activation of EGFR and acinar cell dedifferentiation, would explain how TGF-β limits ADM 
formation. In addition, the deregulation of EGFR and p16 expression due to impaired TGF-
β RII signalling observed during pancreatitis resembles what observed in pancreatic cancer. 
During malignant transformation, pancreatic cells lose the function of TGF-β, TGF-β RII and 
p16 genes and significantly increase the expression of EGFR. Thus, alterations of these 
genes are critical not only for the formation of ADM but also for pancreatic tumorigenesis.   
One would expect that accumulating pancreatic damage during the progression of 
pancreatitis would be another possible reason for ADM formation. However, we could not 
detect any higher cellular or inflammatory damage in late stages of pancreatitis suggesting 
that these processes are independent of each other. However, other studies are required in 
our TGF-β RII KO mouse model to demonstrate ADM independence from inflammation. 
While investigating the TGF-β role in ADM formation, we cannot dismiss a possible TGF-
β crosstalk with other signalling pathways. However, the analysis of Akt signalling pathway 
and various growth factors, which can contribute for ADM expansion, for instance EGF, HGF 
and TGFα , did not reveal any alteration in gene expression following TGF-β RII ablation.  To 
investigate more thoroughly whether TGF-β interacts with other pathways like autophagy, 
further analyses of our mouse model are necessary. 
Collectively, our study highlighted a crucial role of TGF-β in two processes of pancreatic 
regeneration. On one hand TGF-β limits acinar cell replication, on the other hand, it acts as a 
tumour suppressor restricting cell dedifferentiation and metaplasia formation. 
 
7.3 Serotonin regulates acinar cell dedifferentiation and ADM formation 
 
As described above, pancreatic regeneration following pancreatitis is characterised by 
proliferation of pancreatic acinar cells and transient formation of ADM. Previously we 
investigated the roles of two anti-mitogenic factors in acinar cell proliferation and 
dedifferentiation. In addition, we were also interested in the role of pro-mitogenic factors in 
these processes.  
Serotonin, a bioactive molecule stored in and released by platelets, induces a mitogenic 
effect on a wide range of cells, both in vivo and in vitro. Serotonin triggers proliferation of 
lymphocytes, hepatocytes, vascular and smooth muscle cells. Furthermore, it also regulates 
the development of certain organs, for instance brain and mammary gland. Some studies 
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have shown that hypothalamic serotonin has a functional role in pancreatic regeneration via 
sympathetic regulation [40]. However, so far no one addressed the question of a direct role 
of serotonin in pancreatic regeneration. To investigate the mitogenic effects of serotonin in 
acinar cells we used two regeneration models: partial tissue loss following 60% 
pancreatectomy and inflammatory damage following cerulein-induced pancreatitis. We 
compared two types of regenerative stimuli because the pancreatic capacity to regenerate 
differs according to the severity of tissue damage.  
While serotonin did not have any effect on acinar cell proliferation and ADM formation after 
pancreatectomy, we demonstrated that it was required for ADM formation during pancreatitis. 
Serotonin necessity for acinar cell dedifferentiation is surprising and can be discussed from 
different perspectives. At first, due to the known mitogenic function of serotonin, one could 
expect elevated acinar cell proliferation and in turn increased ADM formation as a 
consequence of active cell cycling. However, in the absence of serotonin we observed 
increased acinar Ki67 labelling and higher number of acinar cells in M phase than in G2 
phase, while the levels of BrdU and phospho-histone 3 labelling were comparable in the two 
mouse strains. One explanation for this data can be that the absence of serotonin results in 
delayed cell cycle progression and accumulation of cells in the early phases of the cell cycle, 
which would comply with a mitogenic role of serotonin in pancreatic acinar cells. On the other 
hand, serotonin may elicit an anti-mitotic function in the early phases of the cell cycle, so in 
its absence more acinar cells can enter but not complete the proliferation process. To clearly 
define the roles of serotonin in acinar cell proliferation further studies are necessary. 
However, the fact that acinar replication following pancreatectomy was not affected by the 
absence of serotonin, indicated not only that serotonin is not a potent mitogen for acinar 
cells, but also that the requirement of serotonin for ADM formation does not depend 
exclusively on cell cycle regulation. 
Serotonin has been shown to induce the production of pro-inflammatory cytokines [41], which 
might be the second reason for its requirement in ADM formation. However, analysis of mice 
treated with the serotonin precursor 5-HTP demonstrated that the immune response and 
acinar cell dedifferentiation can be uncoupled in the pancreas, because increased acinar cell 
dedifferentiation correlated with reduced inflammation. 
Another cause for serotonin-mediated ADM formation may result from direct stimulation of 
serotonin receptors or transporter. As mentioned previously, different processes occur during 
acinar cell dedifferentiation: release of zymogen granules, down-regulation of terminal 
differentiation genes and up-regulation of progenitor genes. In our study we used transgenic 
mice with strongly reduced levels of peripheral serotonin but normal levels in nervous system 
and showed that serotonin regulates pancreatic acinar secretion by stimulating its receptors 
or transporter in acinar cells and promoting cytoskeletal remodelling. In addition to serotonin-
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stimulated release of zymogens, which is necessary for acinar cell dedifferentiation, we also 
showed that serotonin was required for up-regulation of the progenitor genes Hes1, Sox9 
and Notch1. Collectively, our results stress serotonins’ role in promoting the progenitor state 
of acinar cells by stimulating acinar cell secretion and progenitor genes expression, which 
contribute significantly to ADM development.  
7.4 Pancreatic and other human epithelial metaplasias 
 
The pancreatic epithelium is one of many epithelial tissues, which forms metaplasia after 
exposure to damaging factors. Comparative investigation of pancreatic metaplasia with other 
human epithelial metaplasias might help us identify common features of these pathologies 
and advance our understanding of their molecular regulation and speed up the discovery of 
therapies. 
All epithelial metaplasias are considered a reversible process resulting in substitution of cells 
that are able to survive better under circumstances that are harmful for other cells. Epithelial 
metaplasia is considered an adaptive process resulting in a tissue phenotype change, the 
underlying molecular mechanisms of which are still not completely understood. 
Stratified squamous and glandular epithelium go to metaplasia most often than other types of 
epithelium and organs like stomach, oesophagus, uterus and bladder frequently contain 
metaplastic tissue. The most common epithelial metaplasias are intestinal and squamous. 
Intestinal metaplasia lesions are characterised by the presence of intestinal cell types that 
occurred in ectopic tissue. [42] The best examples of this type of metaplasia are gastric and 
Barretts’ metaplasia. The first develops due to H.pylori infection and the latter due to a 
gastric reflux [42]. Squamous metaplasia is most common in lungs and urinary bladder. 
Smoking, asthma and cystic fibrosis are factors predisposing to lung squamous metaplasia 
formation and vitamin A deficiency, trauma or surgery cause a transformation of urinary 
bladder epithelium. It is not easy to subgroup pancreatic metaplasia because ADM cells are 
not fully characterised after transformation. Pancreatic acinar and duct cells are glandular 
type cells; however, ADM has glandular morphology but does not have secreting function. 
This definition would imply that pancreatic cell changes follow a glandular-glandular 
phenotype, however more evidences are necessary to prove this assumption.  
Epithelial metaplasias contain some similar features among different organs. First, in many 
cases they are associated with inflammation occurring in the damage tissue. Second, 
metaplasia can be initiated when changes occur in the expression of genes that keep a cell 
identity. [43] Third, metaplasia is proliferative and expanding, however it is also reversible 
and ADM is not observed after damage resolution. Fourth, various factors and pathways are 
similarly deregulated in metaplasias of different tissues. Examples of the most commonly 
107 
 
deregulated signalling pathways are Wnt, Notch, Hedgehog, EGFR, Stat3 and NF-κB, 
however the contribution of each pathway or its factors to a different metaplasia is distinct. 
Why is metaplasia important? At first, it is important in the context of regeneration because it 
generates new cells of the same or different phenotype. Undifferentiated or fully 
differentiated cell types can be the cell source for regeneration and understanding this 
process is crucial for the treatment of tissue and organ injuries. A clinical significance of 
metaplasia is based on two reasons. The most critical is that metaplasia predisposes to the 
development of cancer. One of the best studied examples is Barretts’ metaplasia, which is 
considered a precursor of oesophageal adenocarcinoma. Understanding the molecular and 
cellular steps leading to metaplasia could result in the identification of markers suitable for 
diagnostic or in new therapeutic strategies for disease treatment. The other reason why 
metaplasia is clinically important is due to its relevance in cell-based therapies to replace 
damaged cells, tissue or organs. A number of possibilities exist to generate cells for 
replacement and one of them is to transdifferentiate them directly in vivo by adding additional 
factors [16]. In this case, the research on metaplasia is crucial to help identify those factors. 
However, while the results on metaplasia and transdifferentiation from the laboratory are 
encouraging, it is not clear how and when they will be translated to the clinical practice.  
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